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 Burn injuries are among the most devastating of all injuries and a major global public 
health crisis, with fire related burns accounting for approximately 265 000 deaths 
annually. The African continent, most especially Sub-Saharan Africa, has the second 
highest mortality rates (15% of global mortality rates). In South Africa, 3.2 % of the total 
population sustains burn injuries, with 50 % of these cases as children under the age of 
20 years. Studies have also shown that most of these incidences are prevalent within the 
age groups of 0-5 years, and account for the 3rd most common cause of mortality in 
children under the age of 15 years. 
In depth knowledge and understanding of cellular facets of wound healing has allowed 
for a greater stance in the interventions aimed at circumventing problems associated 
with development of effective wound defects treatment regimen. Burn treatment options 
are largely dependent on the degree and extensiveness of burns. A wide body of literature 
exists with regards to traditional as well as current treatment options. These include, for 
instance the use of various forms of skin auto-grafts. Despite such great success with all 
kinds of innovative ideas surrounding the use of autologous skin grafting, lack of available 
donor sites for skin grafts still remains a problem, more so in cases where patients suffer 
burns spanning more than 70% TBSA. This therefore has inspired the design and use of 
bioengineered skin substitutes as well as cultured/non-cultured autologous epidermal 
cells.    
Unfortunately, to date, no tissue engineering technique has fully been able to recapitulate 
the anatomy and physiology of the skin, or has attained the biological stability as well as 
achieving the aesthetic outcome. Several hurdles are yet to be overcome to achieve this. 
Amongst many, inclusion of melanocytes, other skin appendages as well as potential 
progenitor cells is some of the attributes of an ideal 3D skin equivalent. Therefore 
pigmented 3D skin constructs are of great interest as they address not only the issues of 
complete wound healing, but also the aesthetic outcomes. In light of this, correct 
keratinocyte to melanocyte ratios are also of great importance in designing such 
pigmented 3D constructs. Therefore the major aim of this study was to isolate skin 
melanocytes and keratinocytes, and co-culture them at different ratios in order to attain 
optimal pigment production and/or consequent improved wound healing outcome.  
 
xviii 
To determine the best keratinocyte to melanocyte ratio to use in developing pigmented 
3D skin constructs, the following co-culture ratios were used: 5:1, 10:1 and 20:1. 
Proliferation assays were employed to further elucidate the growth dynamics of both 
human skin melanocytes and keratinocytes in either mono- or co-culture system. 
Secondly, FACS was used to develop a reliable technique to be used to separate the two 
cell types from a co-culture system in order to perform downstream analyses. Thirdly, to 
establish the roles of the co-cultured cells in wound healing (with regards to proliferation 
and migration), scratch wound healing assays were employed.  Lastly, FACS was used to 
infer the effect of such ratios on pigment production.  
Our results demonstrated that keratinocytes, compared to melanocytes mono-cultures 
have higher proliferation capacity. On the contrary melanocyte’s proliferation is up-
regulated by the presence of keratinocytes in a co-culture, whereas higher numbers of 
melanocytes in co-culture with keratinocytes resulted in less proliferative keratinocyte 
phenotype. The FACS separation technique worked excellently in identifying 
keratinocyte population from melanocytes, with an almost 100% accuracy. This is shown 
by melanocytes being sorted as 93% of MART-1+ cells in a mono-culture, followed by an 
approximately 5:1 separation of keratinocytes from melanocytes (77% Kc and 17% Mc). 
In vitro scratch assays demonstrated that none of the co-culture ratios was significantly 
superior with regards to wound healing capacities and pigment production, in the 
absence of fibroblast-conditioned medium.  
In conclusion, the 5:1 co-culture ratio seemed to yield a non-significant, yet best outcome 
with regards to wound healing capacity (only in the presence of fibroblast-derived 
factors), thus conferring it as a potential optimal ratio of keratinocytes to melanocytes, to 




CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW  
1.1. Introduction 
1.1.1. Burn statistics 
Burn injuries are among the most devastating of all injuries and a major global public 
health crisis, with fire related burns accounting for approximately 265 000 deaths 
annually (1). Burn injuries have been rated as the sixth most common type of trauma in 
children aged 5-14 years (1, 2, 3). Approximately 95% of fatal fire related burns occur in 
low to middle income countries, as they generally lack the necessary infrastructure to 
reduce the incidence and severity of burns (1, 2). Followed by South East Asia (Figure 
1.1), the African continent, most especially Sub-Saharan Africa, has the second highest 
mortality rates worldwide (15% of global mortality rates) (1). 
 
Figure 1.1: Global fire-burn related mortality rates in 2000 (4). 
Several factors have been implicated in the increased burn injuries incidences in the Sub-
Saharan Africa; these include poverty, mass illiteracy as well as urban migration, thus the 




1.1.2. Epidemiology of burns in SA  
In South Africa, 3.2 % of the total population sustains burn injuries, with 50 % of these 
cases as children under the age of 20 years (5,6).   
 Incidence and prevalence data are particularly lacking in Africa as most reported causes 
of burn injuries are from hospitals, compounded by a further lack of statistics because of 
community-based medicine. Studies have also shown that most of these incidences are 
prevalent within the age groups of 0-5 years, and account for the 3rd most common cause 
of mortality in children under the age of 15 years (6-8). Adolescent females sustain 
household based injuries (7). In older age groups, young males are at increased risk. 
Toddlers sustain burns mostly on the upper body parts due to their exploring nature; 
they touch, pull and grab even hot objects. Burns affecting the perineum, axilla and 
buttocks are difficult to keep clean and frequently lead to infections, with associated 
increased morbidity (9). 
1.2. The skin  
Skin, being the largest continuous organ in the human body, comprises cells which make 
up various layers, including keratinocytes (Kc), melanocytes (Mc), Langerhans cells (LC), 
Merkel cells, and "resident" T-cells (dendritic epidermal T-cells) (Figure 1.2). 
Keratinocytes represent the most abundant cell type and make up the bulk of the 
epidermis (10). Keratinocytes originate from a single layer of ectoderm during gestation. 
These cells then divide and form multiple layers, which will eventually form distinctive 
spinous and granular layers characteristic of the mature epidermis and express a variety 
of differentiation-dependant keratins (11). Keratinocytes exist in varying differentiation 
states, ranging from the undifferentiated, highly proliferative state (basal keratinocytes), 
to terminally differentiated, granular, upper layers of skin (12). Keratin expression is then 
stopped as the cells become cornified, which then forms the uppermost layer of skin, 
which is in constant contact with the environment.  
Resting on the basement membrane are melanocytes (pigment producing cells). 
Melanocyte precursors (melanoblasts) originate from the neural crest cells (13,14) and 
migrate dorso-laterally along the neural tube in order to localise and differentiate into 
mature melanocytes at epidermal layer of skin (15). These cells are intercalated in 
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between keratinocytes, to form a functional epidermal melanin unit (EMU) (16) . In this 
unit, 1 Mc interacts with 36 Kc, However, the ratio in the basal layer of the epidermis has 
been suggested to be approximately 1 Mc: 5 Kc (17,18).  These melanocytes are 
maintained in a less differentiated state (controlled pigmentation and proliferation, 
which mark their differentiated state) and reside in the basement membrane of the 
epidermis under the tight control of TFG-β signalling via keratinocytes ((19-21). The 
involvement of other key growth factors includes the keratinocyte-derived factors such 
as endothelins (ETs) and fibroblast growth factors (bFGFs) have been shown to have a 
profound role in both the regulation of pigmentation and melanocyte proliferation (17).  
The dermal layer is composed of cells of mesenchymal origin; fibroblasts (22), 
fundamentally responsible for replenishment and maintenance of extracellular matrix 
(ECM) (23,24). These cells make up the dermal layer of skin and form two distinct 
regions; the upper dermal layer (dermal papilla), which comprises papillary fibroblasts 
and the deeper dermal layer (reticular dermis) that is made up of less densely populated 
reticular fibroblasts (25). Fibroblasts are not only useful in maintaining the structural 
integrity of the vast majority of vertebrate tissue, but are also the major role players in 
bioengineered skin constructs as they perform the structural role or maintain the skin 
substitute integrity. These cells perform critical roles through their interaction with 
keratinocytes. Studies have implicated this cross talk during wound healing, where 
fibroblasts secrete keratinocyte mitogens to allow for proliferation (26,27), and in turn 
keratinocytes activate fibroblasts (via interleukins) to allow for increased proliferation, 




Figure 1.2: schematic depiction of the skin, showing mainly the epidermis with various 
cells types, as well as part of the dermis (29). 
1.3. Biology of wound healing   
The primary goals of burn treatment options are a rapidly closed wound and regaining of 
functionality of the affected area or body part. However, current treatment modalities 
aim to achieve both minimal as well as aesthetically presentable scarring.  This wound 
care has been greatly impacted by our broadened understanding of biological processes 
involved in wound healing. Wound healing is an orchestrated phenomenon involving an 
overlap between inflammation, new tissue formation (re-epithelisation) and tissue 





Figure 1.3: Schematic representation of stages of normal wound healing: inflammation, 
proliferation, maturation and remodelling (30). 
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1.3.1. Inflammation phase  
This phase of wound healing is initiated within 24 hours post wounding (Figure 1.4) and 
may last for up to 2 weeks during normal wound healing (31). Mast cells produce vast 
amounts of mediators such as vaso-active amines as well as histamine rich granules, 
which result in the leakiness of blood vessels (32), thus allowing for efficient neutrophil 
movement and their subsequent recruitment to the site of injury (33).  At this stage, the 
wound is therefore characterized by redness, swelling, heat and pain.  
 
Figure 1.4: Phases of normal wound healing over time (31). 
The major cellular role players in this phase are neutrophils and macrophages that are 
recruited by surrounding endothelial cells. Endothelial cells express cellular adhesion 
molecules (CAM) such as selectins, which in turn recruit neutrophils to the site of injury. 
This recruitment allows for neutrophils to provide the first line of defense by 
phagocytosis of micro-organisms as well as debris (33). In addition, tissue necrosis factor 
alpha (TNF-α) and interleukin 1 (IL-1) (34,35) are also secreted by activated 
macrophages and neutrophils to aid in initiation of new tissue formation (36).  
1.3.2. New tissue formation (proliferation phase) 
This phase is initiated approximately four days post-wounding and is mainly 
characterized by the loss of contact between epidermal and dermal cells, thereby 
allowing for migration of such cells from their various niches such as the hair follicle. 
Endothelial cells are activated by TNF-α and bFGF to initiate angiogenesis, thus allowing 
for increased blood flow and nutrient circulation. On the other hand, macrophages and 
platelets secrete PDGF and TGF-β (37), which allow for fibroblast migration (38) and 
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proliferation (28). These cells in turn release matrix metalloproteinase (MMP’s) that 
facilitate their movement through the matrix and subsequently express collagen and 
proteoglycans (39). This ultimately results in granulation tissue formation, thus forming 
a scar characterized by a network of blood vessels and capillaries, macrophages as well 
as a population of fibroblasts with randomly organized collagen fibres (40). Finally, 
epidermal stem cells from the hair follicle migrate to the wound edges and start to 
proliferate and differentiate into keratinocytes in order to form the protective outer layer 
(stratum corneum), a process known as re-epithelisation (41,42).  
1.3.3. Tissue remodelling (maturation phase)  
During this phase, a scar matures to form granulation tissue, and may last for up to two 
years post wounding. The type, density and organization of collagen fibres play a pivotal 
role in tensile strength of the healed wound. Mainly collagen type III is deposited, which 
is replaced by type I collagen (43). As extracellular matrix re-organization occurs, there 
is an ongoing collagen synthesis and degradation with the aim of achieving normal skin 
phenotype (a highly organized structure). This process is mainly driven by MMP’s (44). 
However, the result is often a scar with only 80% tensile strength compared to normal 
tissue (45).    
As mentioned earlier that keratinocytes are the major role players in the regaining of 
skin’s physical barrier, it would be important to discuss some of the molecular facets that 
drive that particular re-epithelisation process. These cellular processes include 
keratinocyte migration and subsequent proliferation following injury, alongside the 
dynamic keratin expression profile, which largely drives their phenotypic changes.  
1.4. Keratinocyte migration and proliferation, as well as cytokeratin expression 
profiling in response to wound healing 
One of the vital facets of wound phases is re-epithelialization, which is orchestrated by 
epidermal keratinocytes, wherein upon wounding, these cells (in close proximity to 
wound edge) are activated to a migratory phenotype, followed by a proliferative burst 
that occurs just behind the migrating tongue (46,47). The migratory and proliferation 
role as well as phenotypic changes (at the level of keratin expression profiles; Figure 1.4) 




Figure 1.5: Structure of the epidermis. (A) Schematic illustration of keratinocytes in 
different layers of epidermis, alongside keratins expressed. Mitotically active basal layer 
keratinocytes are characterized by keratins 5, 14, and 15. As they differentiate, 
keratinocytes form suprabasal layers and express K1 and K10. (B) Immunolocalization 
of K5 (green) and K10 (red) in human epidermis. Nuclei are visualized with DAPI (blue). 
Basement membrane is depicted as BM. Adapted from (48)  
1.4.1. Migration  
In response to acute wound injury, suprabasal keratinocytes at the wound margin begin 
to change their keratin (K) expression profiles. These cells normally express a pair of 
keratins 1 and 10. However, ∼8–24 hr after wounding, keratins 6 and 16 are expressed 
(47) and depict keratinocytes with a more activated phenotype (46). This keratin 
expression profile changes allow for the downregulation of cell-cell and cell-substrate 
attachment molecules; desmosomes and hemi-desmosomes respectively. This then 
allows for keratinocyte migration at the wound edge towards the denuded area (49,50). 
The keratin expression profiles are accompanied by the integrin expression profiles of 
keratinocytes during migration, wherein these cells switch the expression from α6β4 to 
α3β1 (51). Keratinocytes’ migration further induces of K6, K16, and K17 expression, 
which in turn is postulated to increase viscoelastic properties of migrating cells (52). 
Accompanied with keratin and integrin expression is the up-regulation of epidermal 
growth factors (EGF) and fibroblast growth factors (FGF-2), leading to further 
keratinocyte migration (53,54).  
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IL-1, IL-6, and TGF-α, are amongst some cytokines that can also modulate migratory 
phenotypes of keratinocytes. For instance, during wound healing, IL-1 has been shown to 
augment secretion of FGF-7 (55) whereas IL-6 allows keratinocytes to respond to 
mitogenic factors, thereby subsequently stimulating migration through the STAT3-
dependent pathway (26). Finally, TGF-β1 can also promote keratinocyte migration by 
stimulating MMPs such as MMP-1, which is expressed abundantly at the wound edges, 
and is thought to sustain keratinocyte migration on type 1 collagen (56,57). Thereafter 
proliferation occurs.  
1.4.2. Proliferation  
The regulation of keratinocyte proliferation is largely dependent on the availability of 
various stimuli, such as that of growth factors, degree of cell differentiation, as well cell 
attachment to the substrate. Studies have shown that the basal keratinocytes have the 
ability to proliferate, while the keratinocytes in the suprabasal layer are of migratory 
phenotype (reviewed by (58,59).  
Similar to migration, growth factor modulation plays a major role in the proliferative 
process, wherein growth factors such as HB-EGF, TGF-α, KGF and IGF-1 aid in stimulating 
keratinocyte proliferation (60). Finally, Imai et al., (1997) (61) has shown that MMPs, 
through their proteolytic activity, not only release growth factors from the wound matrix, 
but could possibly activate such growth factors. After being activated to repair an injury, 
keratinocytes lose the proliferation signals and return to their normal differentiation 
pathway, where the stratification process begins. 
A deeper understanding of how wound healing is orchestrated, and how various cell 
types drive the different stages of wound healing has allowed for scientists to delineate 
burn injuries into distinctive types, or to varying degrees. The next section deals with the 
classification of burns as well as their clinical manifestations. 
1.5. Types of burns 
Burn injuries can be classified into various degrees, depending on how deep they occur 
into the skin. Such burns range from first degree (I, superficial), to fourth degree (IV, full 
thickness) burns (Figure 1.5). Literature had delved greatly into such clinical 
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manifestations, therefore for the purposes of this review, we will not go into details on 
some the anatomical correlates and clinical aspects of various degrees of burn injuries. 
Figure 1.5 gives a broad overview of these aspects.  
 
Figure 1.6: Degree of burns (62)  
In-depth knowledge and understanding of cellular facets of wound healing has allowed 
for a greater stance in the interventions aimed at circumventing problems associated 
with development of effective wound defects treatment regimen. A large body of 
literature exist about various treatment modalities, therefore the next part of this 
literature deals with only some of the current burn injury treatment regimes.  
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1.6. Current clinical treatment options  
Burn treatment options are largely dependent on the degree and extensiveness of burns. 
A wide body of literature exists with regards to traditional as well as current treatment 
options. These include, for instance the use of various forms of skin auto-grafts (63,64), 
use of cultured epithelial sheets (65), use of bio-engineered skin substitutes (64,66,67) 
as well as potential use of stem cell therapy  (68,69). For the purpose of this study, only 
some of the major current treatment advances will be reviewed.  
1.6.1. Autologous skin grafting  
Skin grafting is a technique that has been used for treatment of severe skin defects, more 
so third degree burn injuries as well as in reconstructive surgery (70,71). This technique 
has also played a significant role in treatment of non-healing diabetic foot or leg ulcers 
(72,73). Skin grafting originates in ancient India, where it was used for treatment of 
mutilations of ear, nose and lips (74).  
This technique was performed in various ways, including “slapping the skin of the buttock 
with a wooden paddle until it was quite congested and then, with a leaf cut to proper 
shape as a pattern, cutting out a piece of skin with its subcutaneous fat, transplanting it 
and sewing it into place, uniting it to the freshened edges of the defect” (…as cited in Chick, 
1988 (74)). Since the 19th century, skin grafts have been harvested by means of a device 
developed by Padgett and Hood in the 1940’s (Padgett-Hood dermatome), which yields a 
piece of skin with a defined thickness, thereby resulting in either full thickness skin graft 
(FTSG) or split thickness skin graft (STSG)  (75). Furthermore, these techniques have 
been further optimised to cater for the well-known problem of lack of donor sites 
following extensive burn injuries. Such techniques include amongst many; meshed skin 
grafts as well as micro-skin grafts. Fabrication, clinical application as well as advantages 






Table 1.1: Various types of skin grafts, their development, subsequent pros and cons, as 

















Full epidermis and 
dermal layers of 
skin harvested from 
donor sites  
Has all major skin appendages, 
less susceptible to trauma and 
normal pigmentation is regained 
(72). However, there’s increased 
risk of graft “take”, prolonged 
donor site healing times as well as 









Full epidermis and 
partial dermal layer 
of skin harvested 
from donor sites 
Shorter donor site healing time 
and increased aesthetics (74,76). 
There are increased contraction 







Meek et al., 
1958 
Small pieces of skin 
cut into uniform 
square pieces 
(~3mmx3mm) 
Works efficiently on extensive 
burns 9~70% TBSA) and spacing 
in between the uniformly layers 
skin pieces allows for uniform re-




Zhang et al., 
1989 
Minute skin pieces 
(~1mm2), meshed 




onto a fenestrated 
wound dressing 
Excellent graft “take” and higher 
expansion ratios (20:1). 
Associated with increased 
contracture as well as increased 
donor site pain (79-81). 
Despite the widespread use of both FTSG and STSG, and accompanying shortcomings, 
split thickness skin grafts remain the gold standard for treatment of various skin defects. 
A vast body of literature has delved into use of such techniques in treatment of severe 
burns and the interesting case studies are highlighted below.   
Zhao et al., (2012) (64) Reported on a case of a female (32 years), with extensive facial 
burns scars. The group grafted a full face, whole full-thickness skin graft. Ten days post-
operatively, there was a 100% graft “acceptance/take”, accompanied by its survival even 
4 years later. The patient regained her natural smile, normal sensation, as well regaining 
a fully operational mouth and eyes. Most importantly, the technique was accompanied by 
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patient satisfaction, alongside a boost in self-confidence. This technique therefore 
highlights the holistic nature of the therapy as well as an optimal clinical outcome (64).   
Due to the well-known problem of lack of availability of donor skin following burn 
injuries covering more than 50% TBSA, several approaches have been introduced. 
Between 1998 and 2008, Zheng et al., (2010) (82) embarked on a technique where they 
harvested split thickness skin graft (STSG) from scar tissue. Scar tissue grafts were 20cm 
x 20cm x 0.8cm in length, width and thickness. Three reconstructive operations were 
performed on various areas of burn scars at 6-monthly intervals. Most importantly, 
stamp-sized skin was also grafted onto the donor areas.  The patients were followed up 
for 4 years, during which time a 100% “take” rate was observed.  This was accompanied 
by complete donor skin healing exhibiting normal tensile strength and pressure 
resistance of the recipient area up to two years later. This case report highlights the 
significance of using scar tissue STSG, which exhibited similar post-operative outcomes 
such as satisfactory functional recovery and improved appearance, compared to normal 
STSG (82).  
Despite such great success with all kinds of innovative ideas surrounding the use of 
autologous skin grafting, lack of available donor sites for skin grafts still remains a 
problem, more so in cases where patients suffer burns spanning more than 70% TBSA. 
This therefore has inspired the design and use of bioengineered skin substitutes as well 
as cultured/non-cultured autologous epidermal cells.    
1.6.2.  Bioengineered skin substitutes  
Tissue engineering is an interdisciplinary (incorporating material science, regenerative 
biology, as well as proteomics and genomics) approach, where the ultimate objective is 
to develop bio-compatible materials that can be used in repair of damaged tissue. A 
technique of this nature not only requires the use and clear knowledge of support 
structures (bio-materials that mimic the ECM), but also the sources and characteristics of 
cells to be incorporated (77,83).  
To date, no tissue engineering technique has fully been able to recapitulate the anatomy 
and physiology of the skin, attained the biological stability as well as achieving the 
aesthetic outcome. Therefore, current tissue engineering techniques should meet most of 
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the following criteria: easy handling and application onto wound site, appropriate 
physical and biological properties, retaining skin barrier function, while maintaining 
appropriate porosity to allow for cell colonisation and fluid exchange (84,85). 
Furthermore, these techniques should possess adherent cues, controlled degradation 
capacity and advanced sterility (non-immunogenic or non-toxic), alongside decreased 
inflammatory response. They should also facilitate angiogenesis (reviewed by (84,85)).  
Bio-materials 
One of the requirements for tissue engineered skin is the use of bio-materials, which can 
either be naturally occurring (collagen, fibronectin, GAGs, or chitosan) or of synthetic 
origin (various forms of bio-polymers, such as poly-tetra flour ethylene). These 
biologically active matrix scaffolds have been widely used in the development of tissue 
engineered skin substitutes, which have been used to treat several skin defects.  
Due to the limited properties of some of these bio-materials, there have been advances in 
the development of “new age” bio-polymers such as matrigel (collagen, fibrin, laminin or 
elastin) and polyethylene glycol (PEG). As a result of its natural resemblance to the ECM, 
its ability to provide certain signalling cues and to form three-dimensional structure, 
matrigel has gained a lot of momentum in its use in tissue engineering. On the other hand, 
PEG, a molecularly engineered synthetic hydrogel serves as an inert structural platform 
due to its hydrophilic nature (86). One of the major drawbacks of synthetic bio-materials 
is their inability to possess cell signalling cues; thus the requirement of cell adhesion 
peptides. Therefore, this synthetic polymer allows for incorporation of peptides (87), 
thus making it an ideal ECM mimic with cell adhesion and proteolytic degradation 
properties (88).   
Cell sources   
Alongside the requirement of biologically active bio-materials, cells are of equal 
importance as they serve various functions ranging from regaining the physical barrier 
to reconstituting the structural integrity of skin following injury. Reliable cell sourcing 
and routine isolation methods are pivotal for large scale production of cell for tissue 
engineering (89). Such cells can be sourced from various platforms, such as local sites 
(where fibroblasts, keratinocytes, melanocytes and adipocytes can be harvested), 
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systemic (blood or circulating bone marrow cells) as well as from progenitor cell 
populations (MSCs or bone marrow derived stem cells). Various skin cells are used for 
the development of varying types of tissue engineered skin substitutes, ranging from 
epidermal to dermo-epidermal substitutes, as reviewed in this section. This section deals 
with the various tissue engineered platforms, the clinical outcomes as well as their 
shortcomings.  
1.6.2.1. Epidermal substitutes  
1.6.2.1.1. Cultured epidermal sheets  
Cultured epithelial autografts (CEA) are defined as thin sheets (3-5 cell layers) of 
epidermal keratinocytes (Figure 1.7), that can either be cultured on synthetic materials 
such as petrolatum gauze (Epicel®) or silicone membrane (Epidex®) to confluence or sub-
confluence (90). Culturing process takes approximately 3-5 weeks post harvesting, which 
is subsequently followed by their transplantation as epidermal sheets to treat various 
skin defects (Figure 1.6) (Table 1.2). Recently this technique has evolved to use of 
stratified cultured epidermal sheets, as a result of pioneering work by Bernstam et al., 
(1986) (91) and Prunieras et al., (1983) (92), who developed a method of in vitro 
stratification of keratinocytes by exposing them to air-liquid interface. This allows for 
spontaneous stratification. 
 
Figure 1.7: Structure of CEA. Adapted from Wood, (2006) (93). Keynote presentation at 




Since their development by Green et al., (1979) (89), CEA have been extensively used as 
early as 1980’s in treatment of severe burns (where patients have suffered burns of more 
than 50% total body surface area). This large surface area coverage of CEA has allowed 
them a platform to circumvent problems associated with lack of donor sites in the burn 
treatment modality arena (90,94,95).  For instance, early studies by Gobet et al., (1997) 
(90) demonstrated potential use of this technique on pediatric burn injuries. It was also 
shown that the grafts persisted for over 2.5 years post transplantation, thereby 
highlighting the importance of CEA’s ability to “take” and persist. Similarly, Cirodde et al., 
(2011) (95) used CEA in the treatment of 68 severely (80% TBSA, with 70% of burns as 
full thickness) burned patients. The group showed a 60% “take” success rate, which was 
attributed to age of patients.  
Despite their desired use in the treatment of large skin defects and their persistence at 
injury sites, CEA are not without any shortcomings. This technique has been shown to be 
expensive, with complex application. Due to their nature (thin epidermal sheets), CEA are 















Table 1.2: The clinical use of (and product description) of various commercially available 
CEA.  
Technology  Company  FDA approval  Brief product summary  
Epicel®  Genzyme Bio 
surgery 
(Cambridge, MA) 
2007 Autologous keratinocytes 
cultured from patient skin 
biopsy, transplanted as 
epidermal sheet using 
petrolatum gauze support. 
Permanent wound closure in 
patients with burn with greater 
than 30% TBSA injury and in 
patients with congenital nevus 
(90,94). 




Clinical trials Autologous keratinocytes 
isolated from 
outer root sheath of scalp hair 
follicles; 
Supplied as epidermal sheet 
discs with a silicone membrane 
support. Treatment of chronic 








2006 Autologous undifferentiated 
keratinocytes cultured from 
patient skin biopsy to sub-
confluence and transplanted as 
a suspension. Treatment of 
deep and extensive wounds 
(97). 
 
1.6.2.1.2. Cultured/non-cultured epidermal cells in suspension  
Due to the prolonged waiting period of culturing partially differentiated autologous 
epidermal sheets, variability in product quality (cell numbers and yield), their fragile 
nature and difficulty to apply, associated poor “take” in shear prone areas as well as high 
costs (98), several studies have explored the use of (spraying) highly proliferative, 
undifferentiated sub-confluent epidermal keratinocyte cells in a suspension (97,99-102).  
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Since the 80’s, use of non-cultured isolated keratinocytes in fibrin gel, known as 
keratinocyte-fibrin gel suspension (KFGS) onto patients with full-thickness burns and 
chronic wounds inspired the much appreciated use of non-/cultured CEA in suspension. 
Since the work done by Horch as well as Wood in the early 90’s, the use of cultured sub-
confluent KFGS for treatment of various skin defects became a much appraised technique 
(100,101,103,104).  
For instance, Stoner and Wood, (1999) (97) demonstrated that CEA in suspension can be 
incorporated and persist in the recipient skin for about 3 weeks, thereby implying that 
wound healing was not a result of release of growth factors, rather of the direct 
incorporation of donor cells. Similarly Hartmann et al., (2007) (99) sprayed cultured 
keratinocytes onto prepared wound beds of deep dermal burn (face and neck) victims. 
They showed that the technique offered an excellent cosmetic outcome, with no adverse 
effects.  
Such cultured epithelial autografts have numerous advantages: they are rapidly available 
(after 10 days of culture), can be harvested from same patient (autologous), with the 
advantages of being site matched, they offer reliable wound adherence with minimal 
donor site morbidity. Such grafts are clinically manageable, affordable and have been 
implicated in improved quality of scar (review by Horch et al., (2005) (98)).  
However, the lack of dermal support has rendered use of CEA (as sheets or in suspension) 
undesirable for treatment of major full thickness burns, thereby highlighting the 
importance of use of dermal components, to provide support and restore mechanical 
strength of transplants.  
1.6.2.2. Dermal substitutes 
Dermal substitutes offer mechanical support and allow for cell and vascular invasion. 
They have been shown to retain moisture and increase surface adherence of cells, as well 
their superiority in biodegradability capacity (105). This therefore renders tissue 
engineered dermal substitutes, great candidates for temporary wound closure and 
mechanical support as the neo-dermis is formed.   
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In the early 80’s Burke et al., (1981) (106) pioneered the development of dermal 
substitutes. Since then, such substitutes gained a lot of momentum in tissue engineering 
and regenerative medicine (Table 1.3). Some tissue engineered dermal substitutes are 
made of cultured human fibroblasts (in a 3D environment; polymer scaffold), thereby 
secreting growth factors and ECM components, which remain active following 
cryopreservation (107). On the other hand, synthetic dermal substitutes are made of a 
bilayer of bio-degradable ECM components such as collagen and chondroitin (Integra®) 
or on synthetic scaffolds (TransCyte®/ Dermagraft® ), and serve as temporary dermal 
support until an autograft is ready (108,109).  Other dermal substitutes are made of a 























Table 1.3: The clinical use of (and product description) of various commercially available 
dermal substitutes. 
Technology  Company  FDA approval Brief product summary  
Integra Integra Life 
Sciences, 
(Plainsboro, NJ) 
1996 Bilayer structure; 
biodegradable dermal layer 
made of porous bovine 
collagen-chondroitin-6-sulfate 
matrix; temporary epidermal 
layer made of synthetic silicone 
polymer. Grafting of deep 
partial- or full-thickness burns; 
epidermal layer removed when 








2010 Structurally intact allogeneic 
acellular dermis; freeze-dried 
after cells were removed with 
detergent treatment; 
rehydrated before grafting. 
Dermal template for grafting to 
burns and other wounds; repair 






1997 Allogeneic neonatal foreskin 
fibroblasts seeded on nylon 
mesh; freeze-dried to kill cells 
and preserve dermal matrix. 
Temporary covering for excised 
deep partial- and full-thickness 







2001 Cryopreserved allogeneic 
neonatal foreskin fibroblasts 
seeded on bioabsorbable 
polyglactin mesh scaffold; cells 
are metabolically active at 
grafting. Treatment of full-
thickness chronic diabetic foot 
ulcers (107). 
Extensive clinical trials have been undertaken to validate the safety and efficacy aspects 
of now commercially available dermal substitutes. Heimbach et al., (1988) (108) embarked 
on a clinical trial where they enrolled 149 patients who suffered burns spanning 
approximately 50% of TBSA. Twenty six of these patients were followed up for at least 
one year post treatment. The group showed that recipients of Integra® exhibited 80% 
“take” rate, and that these patients preferred this treatment modality as compared to 
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meshed autografts and normal wound dressings.  However, infection rates seemed to 
significantly lower the “take” rates, therefore a multi-centre post approval clinical trial 
had to be put in place. This is where Heimbach et al., (2003) (110) enrolled a larger cohort 
of 216 patients, and they showed host dermal regeneration 2-3 weeks post 
transplantation. They further demonstrated a “take” rate of 70%, accompanied by lower 
infection rates, thereby postulating (along with other authors) that dermal substitutes 
could be used in treatment of severe pediatric and adult burns (106,115).    
Despite the great success of dermal substitutes as scaffolds used in treatment of full 
thickness burn wounds, there are some considerable problems associated with this 
technique. Firstly, most of the FDA approved dermal substitutes serve only as temporary 
scaffolds (excluding Integra). Secondly, these substitutes cannot be exclusively used as 
they lack the epidermal (physical barrier) component, thereby highlighting their 
dependence on subsequent use of epidermal autografts (115,116).  
1.6.2.3. Dermo-epidermal substitutes 
Due to their fragility and susceptibility to infections (65), CEA need dermal supports as 
advanced tissue engineered modalities for treatment of skin defects. On the other hand, 
dermal substitutes due to lack of epidermal layer have been shown to be useful as 
temporary scaffolds (116). This reciprocity has therefore allowed for the sequential 
application of dermal application followed by epidermal replacement. However, several 
problems arise with such a technique, whereby studies have shown delayed CEA 
propagation on dermal substitutes as well as increased complexity of transferring fragile 
CEA sheets onto dermal scaffolds autografts (115,116). For these reasons, tissue 
engineering techniques as well as regenerative medicine has allowed for the 
development of dermo-epidermal substitutes such as the FDA approved Apligraf® and 
OrCell®, as well as many other techniques (TissueTech Autograft System and Stratagraft) 
that are still in clinical trials (Table 1.4).  Figure 1.8 illustrates an overview of epidermal-




Figure 1.8: Fabrication of human skin-equivalent (HSE) tissues. Assembly of HSE involves 
preparation of cellular collagen layer, which serves as a dermal equivalent containing 
fibroblasts (A). After 7 days, keratinocytes are seeded on top of this contracted cellular 
layer (B). Developing tissues are maintained submerged in media for 7 days, and then 
lifted to an air-liquid interface to allow full stratification (C) (117). 
Many of these dermo-epidermal substitutes have widely been used in treatment of acute 
surgical wounds (118), venous ulcers (119)  and other skin diseases (66), but not in the 












Table 1.4: The clinical use of (and product description) of various commercially available 
epidermal-dermal substitutes.  




1998 Bilayered human skin directly 
applied to a wound (burns and 
ulcers). Made of allogeneic 
neonatal foreskin fibroblasts 
and keratinocytes in bovine 
collagen gel. Treatment of leg 
ulcers and acute surgical 
wounds (66,119). 




2001/2008 Bilayer; allogeneic neonatal 
foreskin fibroblasts and 
keratinocytes cultured in 
bovine collagen sponge. 
Treatment of split-thickness 
donor sites in patients with 











Clinical trials Comprises an autologous 
dermal substitute made of a 
three-dimensional matrix onto 
which autologous fibroblasts 





Stratagraft  StrataTech 
(Madison, WI) 
Clinical trials  Dermal equivalent containing 
human dermal fibroblasts and 
a fully-stratified, biologically 
active epidermis derived from 
NIKS cells (a near-diploid 
human keratinocytes cell line). 
Treatment of severe burns and 
other skin defects (118,123). 
1.7. Study rationale  
Despite the success and clinical benefits of application of cultured 3D skin substitutes in 
treating burn wounds, these skin substitutes are devoid of many of the structures and 
functions of uninjured skin. Such include sebaceous glands, hair follicles, basement 
membrane, endothelial cells, nerve cells; immune cells and most importantly 
melanocytes (for re-pigmentation) (see review by Supp, (2012)  (124)). Lately, to 
clinicians the best clinical outcome to burn victims is indeed not only a rapid healed 
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wound, but also a satisfactory aesthetic outcome. Therefore the implementation of 3D 
skin constructs (pigmented skin equivalents - PSE) that are made of both epidermal cells 
(melanocytes and keratinocytes) and indeed dermal (fibroblasts) cells is an interesting 
design to explore. For this reason, the mechanism of epidermal cells’ interactions with 
respect to wound healing and repigmentation (due to the presence of melanocytes) is 
pertinent to explore. In light of this, correct keratinocyte to melanocyte ratios are also of 
great importance in designing such pigmented 3D skin equivalents.  
1.8. AIM 
The overall aim of this study was to, through the use of primary isolated skin melanocytes 
and keratinocytes develop an in vitro co-culture system to obtain optimal pigment 
production in vitro and its applicability to an improved wound healing outcome.  
1.9. Objectives 
To address the above aim, the following objectives were formulated:   
 To understand the growth dynamics (by means of proliferation assays) of both 
human skin melanocytes and keratinocytes in either a mono- or co-culture system  
 To develop a reliable technique to separate the two cell types from a co-culture 
system in order to perform downstream intercellular analyses  
  To develop a co-culture system at different ratios of epidermal cells and to analyse 
the effect such ratios have on pigment production 
  To analyse the effect the co-cultured cells have on characteristics associated with 





CHAPTER 2: MATERIALS AND METHODS 
2.1. Standard operating procedures and materials  
2.1.1. Primary skin cells and cell lines used in this study 
Primary human skin melanocytes and fibroblasts as well as immortalised human 
keratinocytes (HaCaTs; which will be referred to as keratinocytes) (125) were used in 
this study. Melanocytes and fibroblasts were harvested from infant foreskins using a 
modified method (126). See Figure 2.1, schematic overview of isolation and culturing 
protocol below. Please note that all cells and tissues obtained for this study was ethically 
approved with consent (REC REF 493/2011). 
 
Figure 2.1: A schematic overview of the isolation and culturing protocol of human 
foreskin primary keratinocytes, melanocytes and fibroblasts. 
 
2.1.1.1. Isolation of human foreskin melanocytes 
Briefly, neonatal foreskins were transported in 10ml Dulbecco’s Modified Eagle’s Medium 
(Highveld Biological, SA; Appendix A) supplemented with 100U/ml Penicillin/ 100µg/ml 
Streptomycin (Sigma, SA; Appendix C) upon collection from the hospital. Aseptically, 
excess adipose tissue was removed from the foreskins and they were cut into thin, long 
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at 4°C overnight to allow for dissociation of the epidermis from the dermis. The following 
day, the thin pieces were placed in PBS (Appendix B) supplemented with antibiotic and 
the epidermis was gently separated from dermis with two fine forceps (KIMIX, RSA). 
Using a rounded scalpel blade (KIMIX, RSA), the epidermis (for melanocytes) was then 
chopped into further small pieces and transferred into 5ml of 0.1% trypsin with 0.02% 
EDTA (TE, Appendix C) to obtain a single cell suspension. The suspension was incubated 
at 37°C in a water bath (Memmert, Germany) for 15mins with gentle agitation every 
5mins (the trypsin became cloudy as single cells were released from tissue). The tissue 
suspension was then triturated and transferred into a 15ml tube (Greiner Bio-One, 
Germany). Trypsin was inactivated with 1/10 volume of FCS (Appendix C), with further 
trituration. To remove debris, the cell suspension was filtered through a 70µm filter (BD 
Biosciences, USA), followed by centrifugation at 1000g for 10 minutes (MSE LTD, 
London). The pellet was re-suspended with melanocyte specific medium; FETI (Appendix 
A) and the cells seeded into 6cm culture dishes (Greiner Bio-One, Germany) and 
incubated (5% CO2/95% O2, Sanyo, Japan) at 37oC for two days to allow for cell 
attachment. No melanocyte cultures used in this project exceeded 11 passages. 
2.1.1.2. Isolation of human foreskin fibroblasts  
Using the same preparation procedure (section 2.1.1.1), primary human foreskin 
fibroblasts were harvested. Following collection and dispase treatment overnight and 
cutting of tissue into small pieces, 2ml of complete medium was added, while holding the 
cover slip down with a 1ml pipette tip (Greiner Bio-One, Germany). The small pieces of 
tissue under cover slips were incubated at 37oC. Fibroblast outgrowths were cultured 
until confluence with a change of medium every second day. Cells were expanded at 
confluence and frozen until needed. No fibroblasts used in this study exceeded 11 
passages.  
2.1.2. Tissue culture conditions 
Melanocytes were cultured in specialised medium (FETI; Appendix A), while 
keratinocytes were cultured in DMEM supplemented with 10% v/v heat inactivated fetal 
bovine serum (Highveld Biological, SA; Appendix C) and 100U/ml Penicillin/ 100µg/ml 
Streptomycin. The co-culture medium (GREENS; Appendix A) was used when the 
melanocytes and keratinocytes were cultured together for different assays.  All cells were 
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cultured in a tissue culture incubator at 37oC with humidified 5% CO2/95% O2. Medium 
was changed every 3rd day and cells were passaged by means of trypsinization with 
trypsin/EDTA at confluence. These cells were routinely checked (every month) for 
mycoplasma using the nuclear stain, Hoechst 33342 (Appendix C). 
2.1.3. Growth dynamics 
One of the simple methods of inferring in vitro growth dynamics of cells is by means of 
growth curves. This method allows for counting of cells over a specified time period. In 
this study, monoculture growth curves were completed. Briefly, the cells (2x104) were 
seeded in 35mm dishes (Nest Biotechnology, China) and cultured for a period of 7 days. 
At days 1, 2, 3, 5 and 7, the cells were trypsinised off the dishes by standard methods and 
counted using a 0.002mm2 Neubauer counting chamber (Superior Marienfeld, Germany). 
All experiments were conducted for a minimum of 3 times (n=3) containing duplicates 
within each experiment. The growth curve results were plotted as mean ± SEM values.  
2.1.4. Co-culture models and culture conditions 
Keratinocytes and melanocytes were co-cultured in GREENS medium as indicated in 
Section 2.1.2. Table E1-E4 (Appendix E) indicates the numbers of cells used for various 
co-culture experiments.  
2.1.5. Scratch assays 
A scratch assay is a simple in vitro wound healing simulation model used to observe and 
measure migration and/or proliferation of a monolayer of cells into a denuded area 
(127). In this study, in vitro scratch assays were performed through combining 
keratinocytes and melanocytes at various ratios, as indicated in Table E1 (Appendix E). 
Cells were pre-mixed in 1.5ml microfuge tubes and seeded onto 35mm glass coverslips 
(Superior Marienfeld, Germany) in 35mm tissue culture dishes and cultured for 24 h to 
70-80% confluence prior to wounding. 
A scratch “wound” was made with a 1ml micropipette tip, using a ruler as a guide to 
obtain consistency across the cover slip (Figure 2.2). Debris and floating cells were 
removed by washing with medium, followed by addition of 2ml fresh medium. Three 
images (top, centre and bottom of scratch, as indicated in boxes, Figure 2.2) per tissue 
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culture dish were taken immediately and were used as control images (denoted as time 
zero).  Thereafter, images were taken at specified time periods (denoted as times “n”).  
 
Figure 2.2: A schematic depicting a scratch assay made by the use of a 1ml micropipette 
tip, aided by a ruler.  
The scratched co-cultures were cultured for a period ranging from 48 hours to 8 days at 
37oC. Camera images (EVOS, life Technologies, SA) were captured at various time points 
during wound healing (three images at each time-point).  Wound closure was calculated 
using Image J software (version 1.43u; National Institutes of Health, USA). Briefly the 
denuded area on the scratch was measured for each of the three images at each time point 
(Figure 2.3). Percentage wound closure was subsequently calculated as per the equation 
below (where “t” is time, “n” is time post wounding): 
 
Figure 2.3: Image showing how a scratch is measured to depict percentage wound 
closure at various time points.  
Cells on cover slip
35mm dish 
Denuded area 
Made with Micropipette tip 
(1ml), 
using ruler 
Area where 3 








2.1.6. Fluorescent activated cell sorting (FACS) 
Fluorescent activated cell sorting (FACS) is a technique used to sort cells according to size 
and granularity. Cells can be tagged with fluorescent dyes and/or antibodies and then 
sorted. In this study we aimed at separating keratinocytes and melanocytes (in a ratio of 
5:1, 10:1 and 20:1) from a co-culture in order to perform further analyses. Briefly, cells 
were cultured as either mono or co-cultures in specific medium for 24 hours. Cells were 
then trypsinised and centrifuged for 5 minutes at 2 500 rpm. The resultant pellet was 
washed twice in PBS, with centrifugation for 1 minute at 2 500 rpm between each wash. 
The cells were re-suspended and fixed in 2ml of cold 4% paraformaldehyde (Appendix 
C) for 15 minutes at ambient temperature and washed twice in PBS. Cells were then 
permeabilized for 15 minutes using a perm/wash buffer (BD Biosciences, USA) following 
manufacturer’s instructions.  Cells were re-suspended in FACS buffer (R & D Systems, 
USA) and transferred to FACS tubes (BD Falcon, USA). Finally a specific fluorescent 
antibody (Section 2.2) was added to the cell suspension and tubes were covered with foil 
to prevent light exposure. The cells were incubated for 1 hour at ambient temperature on 
a shaker (The Belly Dancer, Stoval Life Sciences. USA) and washed with “perm/wash” 
buffer. The cells were then re-suspended in FACS buffer and immediately acquired 
(10 000 events or total cell population) on a flow cytometer (FACS Aria; BD Biosciences, 
USA).   
2.1.7. Harvesting of fibroblast conditioned medium 
Primary human foreskin derived fibroblasts at passages 5-7 were used in this study to 
harvest fibroblast conditioned medium, which was subsequently used to infer the effect 
of fibroblast-derived factors on our in vitro co-culture models. Firstly these primary cells 
were isolated and cultured as mentioned in Section 2.1.1. Fibroblasts were seeded into 
10cm dishes in complete DMEM to reach 70-80% confluence and cultured for a further 
24hrs to enrich the medium. The resultant medium was collected into 15ml tubes, 
centrifuged at 2 000rpm for 2 minutes to remove all debris and medium was transferred 
into new tubes and further filtered through a 0.25µm filter (Sartorius Stedim 
% wound closure  = X 100
[wound area (t0) – wound area (tn)]
Wound area (t0)    
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Biotechnology, Germany) to remove any finer debris. The resultant conditioned medium 




















2.2. Experimental setup 
To address the aims and objectives of this study, the following specific experimental 
procedures were undertaken. Figure 2.4 below depicts the schematic workflow.  
 
 
Figure 2.4: Schematic/overview of experimental setup followed in this study.  
 
Optimisation of culture conditions 
FACS: Cell type separation technique
Labelling of co-cultures with MART1-FITC 
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healing in co-culture ratios  
Growth of Mc mono-cultures





48 hr in vitro scratch + Mitomycin C: Evaluation 
of exclusive cell migration during wound healing  
48 hr in vitro scratch + Fb-CM: Effect of 
fibroblast-derived factors on wound healing in 
co-culture ratios 
48 hr in vitro scratch + Fb-CM + Mitomycin C: 
Effect of mode of action of fibroblast-derived 
factors on wound healing in co-culture ratios 
Growth of Mc and Kc co-cultures
Proliferation Index (FACS): Evaluation of proliferative 
capacity post scratch
Melanogenic Index (FACS): Evaluation of 
pigmentary phenotype in co-cultures
MART-1 + /Ki-67- cells
(non-proliferating Mc)
MART-1 + /Ki-67+ cells
(Proliferating Mc)
MART-1 + /TRP-1- cells
(non-melanogenic Mc)




2.2.1. Co-culture growth dynamics 
Three ratios of co-cultures of keratinocytes to melanocytes were used. These included 
5:1, 10:1 and 20:1 keratinocytes to melanocytes, respectively. 
In this study we used FACS to separate melanocytes and keratinocytes from a co-culture. 
This dynamic approach allowed us to count melanocytes (as a Mart-1-FITC positive 
population) and keratinocytes (as a FITC negative population). Therefore, co-culture 
growth dynamics were evaluated by means of growth curves, wherein FACS was used to 
separate the cells. Briefly, cells were seeded (as indicated in Table 2, Appendix E) and 
cultured for 7 days. At days 1, 3, 5 and 7, cells were trypsinised, and then washed with 
PBS. Thereafter, they were fixed and permeabilised (Section 2.1.6). The cell suspension 
was then labelled with 1µg of melanoma antigen recognised by T-cells (MART-1) 
conjugated to FITC (Santa Cruz Biotechnology, SA), followed by acquisition by means of 
FACS (wherein a total number of both melanocytes and keratinocytes in co-culture was 
established).   The Mart-1+ cells were melanocytes, while Mart-1- cells were acquired as 
a negative population.   
2.2.2. Evaluation of melanogenesis in co-cultures  
2.2.2.1. TRP-1 expression analyses (melanogenesis) 
Using the FACS approach, we evaluated the melanogenic capacity of melanocytes in 
various co-cultures. We used TRP-1, which is a melanocyte-specific enzyme involved in 
melanin synthesis. It catalyses the last step in the melanogenic pathway, resulting in 
formation of eumelanin.  
For this, cells were seeded (as indicated in Table 3, Appendix E) and cultured for 3 days. 
At days 0 and 3, cells were trypsinised, fixed and permeabilized as before (Section 2.1.6). 
The cell suspension was then double-labelled with 1µg of MART-1 (FITC) (Santa Cruz 
Biotechnology, SA) and TRP-1 (Alexa 647) (Santa Cruz Biotechnology, SA). Cells were 
acquired by means of FACS (wherein a total number of MART-1+/TRP-1+ melanocytes in 
co-culture was established as a melanogenic population).     
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2.2.3. Evaluation of in vitro wound healing using various co-culture ratios (48hr 
scratch) 
In order to determine the ratio of cells in a co-culture, which yields an optimal wound 
healing phenotype, both keratinocytes and primary foreskin melanocytes were seeded at 
various ratios (see Table E1, Appendix E) on cover slips (section 2.1.5), for 24 hours. Co-
cultures were then scratched and images were taken at 0, 12, 16, 20, 24 and 36 hours 
post-scratch (Figure 2.5). Image J software was used to calculate the denuded area over 
time and the percentage wound closure was calculated.  
 
Figure 2.5: The in vitro wound healing protocol of various co-culture models (5:1, 10:1 
and 20:1), over a 36 hour period post scratch. 
2.2.3.1. Evaluation of cell migration during wound healing (Mitomycin C 
treatment) 
Cells have been shown to close the wound via two exclusively mutual events; migration 
and proliferation. For this study, it was of great interest to infer how cells in a co-culture 
close the in vitro wounds. As previously mentioned, various ratios (5:1, 10:1 and 20:1) of 
co-culture models were seeded for 24 hours onto coverslips in 35mm dishes, followed by 
treatment with 0.01 µg/µl of mitomycin C (a mitogen inhibitor) for 2.5 hours. The 
medium with treatment was then removed and cells were washed twice with complete 
medium, followed by addition of fresh medium. The cells were then scratched and images 
were taken at 0, 12, 24, 36 and 48 hours post-wounding (Figure 2.6). Percentage wound 
closure was calculated as before.  
Take images (3 fields of view/ time point) 
t=0 t=12 t=16 t=20 t=24 t=36 
Scratch cells  
 cell ratios (5:1, 10:1, 20:1 ) 




Figure 2.6: The in vitro wound healing protocol of various co-culture models (5:1, 10:1 
and 20:1) over a 48 hour period, following addition of mitomycin C.  
2.2.3.2. Determination of Proliferation index in various co-culture ratios,     
during wound healing  
FACS was utilised to measure the proliferation index (PI) of co-culture ratios (5:1, 10:1 
and 20:1). Briefly, cells were cultured for 24 hours in co-culture. The cells were scratched 
as before and at the following time points (24 and 48 hours) post-scratch, cells in 
suspension were fixed, permeabilised (as outlined in section 2.1.6) and dually labelled 
with 1µg and 2µg of MART-1 (FITC) and Ki-67 (PE) (Santa Cruz Biotechnology, USA), 
respectively. At each time point, the index (PI) was calculated using the following 
formula:  
 
Equation depicting calculation of proliferative index (PI)  
 
Figure 2.7: The schematic, representing the proliferative index (PI) protocol. 
Take images (3 fields of view/ time point) 
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Total number of cellsPI = X 100
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Scratch cells  
 cell ratios (5:1, 10:1, 20:1 ) 
 35mm dishes 
t=48 
Trypsinize, fix, permeabilize, label with Mart-1 and Ki-67, acquire on FACS
 
35 
2.2.4. Effect of human fibroblast growth factors on wound healing (Fb-
conditioned medium) 
In order to evaluate the effect of fibroblast-derived factors on in vitro wound healing, we 
harvested fibroblast-conditioned medium, which was then added to our co-cultures. 
Briefly, the various cell ratios were seeded for 24 hours (section 2.1.5). Human fibroblast 
conditioned medium (harvested as outlined in section 2.1.7) was added to the cells in a 
1:1 dilution (growth medium: conditioned medium). The cells cultured in a 1:1 ratio of 
DMEM (fibroblast growth medium) to respective growth medium were used as the 
control. The scratches were introduced onto these cell mono-layers and images were 
taken. Images were taken at times 0, 12, 24, 36 and 48 hours post-wounding (Figure 2.8).  
 
Figure 2.8: Protocol followed in determining the effect of human fibroblast growth 
factors on wound healing.  
2.2.4.1. Evaluation of mode of action of fibroblast growth factors in wound healing 
(Fb-conditioned medium and Mitomycin C treatment) 
In order to investigate how the fibroblast conditioned medium influences in vitro wound 
healing, ratios (5:1, 10:1 and 20:1) of co-culture models were seeded for 24 hours onto 
cover slips in 35mm dishes, followed by treatment with 0.01 µg/µl of mitomycin C (a 
mitogen inhibitor) for 2.5 hours (Section 2.2.4). Cells were scratched; images were taken 
at 0, 12, 24, 36 and 48 hours post-wounding (Figure 2.9) and percentage wound closure 
was calculated. 
Take images (3 fields of view/ time point) 
t=0 t=12 t=24 t=36 
HFb-CM
Scratch cells  
 cell ratios (5:1, 10:1, 20:1 ) 





Figure 2.9: Evaluation of mode of action of fibroblast growth factors in wound healing 
protocol.  
2.3. Statistical analyses  
All data were presented as mean ± SEM. One way analysis of variance (ANOVA) with 
Bonferroni post hoc test was used to determine statistical significance. A value of P<0.05 
was considered significant. All the graphs and statistics were performed using GraphPad 
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CHAPTER 3: RESULTS AND DISCUSSION 
Despite the promising success and clinical benefits of using cultured 3D skin substitutes 
in treating burn wounds, their main disadvantage is the fact that they are devoid of many 
of the structures and functions of uninjured skin. These include amongst many, hair 
follicles and melanocytes (124). Furthermore, to clinicians, the best clinical outcome for 
burn victims is indeed not only a rapidly healed wound, but also a satisfactory aesthetic 
outcome. The inclusion therefore of pigment producing cells (melanocytes) in 3D skin 
constructs is of great importance. In light of the melanocytes and keratinocytes forming 
a functional epidermal melanin unit, correct keratinocyte to melanocyte ratios are of 
great importance in designing pigmented 3D constructs.  
This study was aimed at isolating skin melanocytes from human skin samples, followed 
by co-culturing of these cells together with keratinocyte cell line at different ratios in 
order to determine the optimal keratinocyte: melanocyte ratio which would ultimately 
yield the best pigment production and/or consequent improved wound healing outcome. 
Clinically, this data would be useful in the future design of pigmented 3D skin constructs.  
One of the main objectives of this study was to use in vitro co-culture models to evaluate 
the cellular mechanisms of wound healing. To meet this objective, various ratios of 
human keratinocytes (HaCaTs) to melanocytes (5:1, 10:1 and 20:1) were used to infer 
how such cells migrate and/or proliferate into in vitro scratch assays. Since the culture 
system involved two different epidermal cell types, their growth dynamics had to be 
evaluated. We therefore cultured melanocytes and keratinocytes as either mono- or co-
cultures and evaluated their growth rates over a 7 day period.  
3.1. Mono-culture growth dynamics  
Keratinocytes, in a mono-culture exhibited a much faster growth compared to 
melanocytes (Figure 3.1), with a population doubling time of 0.6 days. This corroborated 
early work by Boukamp et al., (1988) (125) where they reported a doubling time of 1 day. 
Both keratinocytes and melanocytes in culture exhibited a classical growth dynamic, 
characterised by a lag phase (~ 2 days in both cell types), followed by an exponential 
phase. During the latter phase, cells exhibited marked differences in growth dynamics, 
with keratinocytes proliferating much faster, from day 5 to 7.   By the end of the growth 
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period (day 7), there were approximately 9-fold more keratinocytes (9 x 105) than 
melanocytes (1 x 105), highlighting the differences in growth dynamics between these 
epidermal cells. The estimated doubling times were 1.63 and 3.39 days for keratinocytes 
and melanocytes, respectively. The doubling time for melanocytes corroborated work by 
De Luca et al., (1988) (128) who showed the primary melanocyte doubling rate of 4 -10 
days.   
Such difference in growth patterns of melanocytes and keratinocytes was expected as 
studies have observed that melanocytes are largely dependent on surrounding 
keratinocytes in vitro and in vivo for survival and maintenance (17,129,130). Therefore 
in mono-culture, melanocyte growth is largely hampered due to the absence of 
contributing paracrine growth factors and mitogens secreted by surrounding 
keratinocytes in vivo or in co-culture.  
 
Figure 3.1: The growth curves of immortalised human keratinocytes and primary human 
melanocytes cultured in DMEM and FETI respectively, for a maximum of 7 days. At days 
1, 2, 3, 5 and 7, cells were lifted and counted. Cell numbers are presented as mean ± SEM 
values. n=3 
3.2. Co-culture growth conditions  
Having confirmed the growth differences of keratinocytes and melanocytes in a mono-
culture, it was pertinent to explore how such differences may be altered in a co-culture 
model. To do this, keratinocytes and melanocytes were co-cultured at ratios of 5:1, 10:1 




























and 20:1 respectively, over a 7 day period. We observed proliferation over time using cell 
separation by FACS and counting the number of events on each day (Figure 3.2). This is a 
unique model that allows for separation of melanocytes from keratinocytes based on the 
positive identification of melanocytes (MART-1+) following labelling of co-cultured cells 
with MART-1 (melanocytes specific antibody). Keratinocytes in turn are sorted as a 
MART-1 negative (MART-1- ) population by FACS (detailed procedure and optimisation 
data are shown in Appendix F and G).  
In a co-culture model, these cells displayed a different growth dynamic, which was largely 
dependent on the co-culture ratio.  
 
Figure 3.2: Proliferation of keratinocytes and melanocytes co-cultures (5:1, 10:1 and 
20:1). Cells were cultured for a maximum of 7 days in Greens. At days 1, 3, 5 and 7, cells 
were lifted, fixed, permeabilised, stained with the melanocyte specific antibody (MART1-
1) and acquired by FACS. 
Though keratinocyte numbers increased with time, melanocytes numbers stayed 
relatively the same (figure 3.3), implying that despite the proliferative capacity of 
keratinocytes (which could bring about competitive growth advantage); melanocytes 
were able to survive in a co-culture for 7 days. This is also in accordance with the study 
by Abercrombie et al., (1964) (45) who also showed that despite the paracrine signalling 































In culture, Swope et al., (2002) (131) reported that melanocytes lacked adequate 
expression of adhesion molecules and exhibited low proliferative capacities, thus 
rendering them unable to sustain themselves in prolonged cultures. Furthermore, 
keratinocytes at high densities are capable of hindering melanocyte growth in culture 
(132). Despite these known limitations, we observed melanocyte survival over a 7 day 
period, amidst the high proliferative activity of keratinocytes in our co-culture models.  
  
Figure 3.3: The growth curves of keratinocytes and melanocytes co-cultures (5:1, 10:1 
and 20:1). Cells were cultured for a maximum of 7 days in Greens. At days 1, 3, 5 and 7, 
cells were lifted, fixed, permeabilised and acquired by FACS. A: Kc represented as MART1- 
cells as cell counts, while B: Mc were sorted as MART1+ cells and presented as a ratio of 











































































































Though there were no significant differences in growth dynamics between all ratios of 
both keratinocytes and melanocytes in co-culture (Figure 3.3A and B), there seemed to 
be marked differences in their population doubling times (PD), wherein we observed a 
vast decline in PD of keratinocytes from a mono-culture into a co-culture (0.6 days in 
mono-culture to about 1.63 days in co-culture). This PD was largely influenced by the co-
culture ratio, where we saw that keratinocytes in a 20: 1 ratio to melanocytes exhibited 
the highest proliferative capacity (PD of 1.29 days compared to 1.76 and 1.37 days in 5:1 
and 10:1 ratios, respectively) (Table 3.1). Moreover, the population doubling for 
keratinocytes was highest in a 5:1 ratio, implying that in this ratio, keratinocyte 
proliferation is slowed.   
Table 3.1: The population doubling times of keratinocyte to melanocytes co-cultures  
 
Ratios 
Population doubling times (days) of cells in a co-culture 
Keratinocytes Melanocytes 
5:1 1.76 1.71 
10:1 1.37 2.04 
20:1 1.29 2.14 
Similar to the keratinocytes, melanocytes exhibited marked ratio-dependant differences 
in growth dynamics. The melanocytes showed the highest proliferative capacity in a 5:1 
ratio, with a PD of 1.76 days, compared to 2.04 and 2.14 days in 10:1 and 20:1 ratios, 
respectively. Furthermore, the melanocytes in a co-culture had a far greater proliferation 
capacity compared to mono-cultures. However, compared to keratinocytes, melanocytes 
still exhibited a slightly slower growth (average PD of more than 2 days for melanocytes 
and PD of less than 2 days for keratinocytes). The slower melanocyte proliferation is in 
accordance with studies that have implicated the tight control of melanocyte growth and 
differentiation in co-culture with keratinocytes (19-21). For instance, it has been shown 
that TGF-β signaling cascade maintains melanocytes in an undifferentiated, non-
proliferative state. This is achieved by the phosphorylation of Smad 2/3 by TGF-β, which 
leads to down regulation of MITF, the master transcriptional regulator of melanocyte 
differentiation, and its downstream melanogenic genes (20).  
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Interestingly we observed an inverse correlation of PD within both keratinocytes and 
melanocytes in co-culture. Where keratinocytes’ proliferation was greatly slowed in a 5:1 
ratio, melanocytes exhibited the highest proliferation rates. This further emphasises the 
reciprocal influence of both cell types on each other in co-culture. 
The results thus suggest that the 5:1 (keratinocyte: melanocyte) ratio may be the best co-
culture ratio as we observed the greatest proliferation of melanocytes (lowest PD of 1.71 
days) and most importantly, this ratio seems to be optimal for synchronisation of 
population doubling times (or growth rates of both keratinocytes and melanocytes) 
(column in bold; Table 3.1).  
The synchronisation of population doubling times of both melanocytes and keratinocytes 
is a vital phenomenon as it implies that for clinical purposes, we would be able to co-
culture these cells in vitro without any delays in the growth of any other cell type. 
Therefore this addresses the known fact that melanocytes grow much slower than 
keratinocytes in mono-culture.  
3.3. Determination of melanocyte and keratinocyte involvement in an in vitro 
wound healing model  
Having confirmed the growth dynamics of the epidermal cells in either a mono- or co-
culture system, we set out to determine the co-culture ratio of melanocytes to 
keratinocytes that would yield the best quantifiable wound healing outcome. To do this, 
an in vitro migratory (scratch) assay was employed. This is a simple technique that 
determines the rate of wound closure following an induced scratch on a mono-layer of 
cells (127,133).  
3.3.1. Involvement of melanocytes and keratinocyte mono-cultures  
Firstly, we evaluated the wound healing capacities of each cell type in a mono-culture. 
The cells were seeded as outlined in materials and methods (Section 2.1.5). A consistent 
scratch (using a 1ml pipette tip cut at the edge, to create a larger scratch) was made on 
the mono-layer of cells (primary keratinocytes or melanocytes) and the cells were 
monitored daily over a 7-day period.  
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As shown in Figure 3.4, significant differences in percentage wound closure at days 3, 4 
and 5 post wounding (3 and 4 days: p < 0.001, while 5 days: p < 0.05) were observed 
between keratinocytes and melanocytes.  Keratinocytes exhibited a 96.8% wound closure 
compared by day 3. Melanocytes in contrast, exhibited a 64.5% wound closure. By day 4 
post wounding, keratinocytes had fully (100% wound closure) closed the scratch, while 
melanocytes showed a 73.6% wound closure. 
 
Figure 3.4: Evaluation of wound closure in melanocyte or keratinocyte mono-cultures. A 
scratch was made 24 hours post co-culturing and wound closure was monitored for 8 
days. Three images per field of view were randomly taken daily and Image J software was 
then used to calculate percentage (%) wound closure.  The % wound closure is 
represented as mean ± SEM, n=3. 
Such significant differences in wound closure by keratinocyte and melanocyte individual 
monocultures may be attributed to the fact that melanocytes have been shown to have a 
low proliferative activity when in mono-culture (131). Moreover, their apparent lack of 
accelerated growth in the absence of surrounding keratinocytes re-emphasises their 
dependence on paracrine factors secreted by surrounding keratinocytes for optimal 
growth. 
3.4. Evaluation of wound closure capacities by co-cultures  
Studies have shown that both keratinocytes and melanocytes secrete paracrine and 
autocrine factors (such as bFGF, ET’s, HGF and α-MSH) that are pivotal to their survival 
and maintenance in vivo (17,128,134,135).   Such factors have also been implicated in 


























their response to cellular stresses such as UV, where melanocytes are stimulated by 
keratinocytes to synthesise melanin (128,136,137).  
To our knowledge, no studies have implicated these paracrine signals in wound healing. 
Therefore in our study, we were interested in determining what effect, if any, these cells 
have on the overall wound healing progression and how they may interact to promote 
this effect at the level of their proliferative potential and migratory phenotypes. To 
understand this, keratinocytes and melanocytes were co-cultured at various ratios (5:1, 
10:1 and 20:1) and accompanying cellular processes (proliferation and migration) were 
analysed via the scratch assay (Figure 3.5).  
 
Figure 3.5: Scratch assay images showing the wound closure of the keratinocyte to 
melanocyte ratios (5:1, 10:1 and 20:1), 0, 12, 24 and 36 hours post wounding. 
Magnification, 100 X.  







During the first 12 hours post wounding, co-cultures exhibited no significant differences 
in percentage wound closure (Figure 3.6). However, significant differences were evident 
at the 20 hour time point with the 20:1 ratio yielding a significantly (97%, p˂0.001) 
higher percentage wound closure compared to 5:1 (58%) and 10:1 (60%) ratios.   By 24 
hours, this had progressed to even more disparate wound closure differences with the 
20:1 displaying a 100% closure as opposed to 80% and 60% for the 10:1 and 5:1, 
respectively. Thirty six hours after wounding, 100% wound closure was evident for all 
the ratios.  
  
Figure 3.6: Determination of wound closure in various ratios of keratinocytes and 
melanocytes co-cultures (5:1, 10:1 and 20:1). A scratch was made 24 hours post co-
culturing. At 0, 12, 16, 20, 24, and 36 hours post scratching, three images per field of view 
were randomly taken using a camera and Image J software was then used to calculate % 
wound closure.  The %wound closure is represented as mean ± SEM, n=3 
These differences in wound closure may be attributed to several factors. Firstly, 
keratinocyte proliferation has been shown to be negatively impacted by the physical 
presence of melanocytes (138). In their study, Deveci et al., (2001) (138) reported that 
cell-cell contact of melanocytes and keratinocytes exerted a negative proliferative effect. 
In contrast, addition of melanocyte-conditioned medium to keratinocyte cultures 
enhanced proliferation. It therefore seems plausible that in the higher keratinocyte to 
melanocyte ratios (10:1 and 20:1), less melanocytes exist to exert this negative impact 
and thus faster closure ensues (Figure 3.6).  


























Based on these results the 20:1 ratio of keratinocytes to melanocytes may potentially 
yield a better wound healing outcome (Figure 3.6). In addition, a significant difference in 
wound healing occurs at around the 20 hour time point (Figure 3.6). Moreover, this 
corroborates our previous finding (Table 3.1), where the keratinocyte numbers increased 
in the 20:1 ratio. However, it does not support the previous observation where the 5:1 
ratio enhanced the population doubling times of melanocytes in co-culture and clearly a 
different mechanism may be at play in that instance.     
3.5. Evaluation of migratory and proliferative phenotypes of co-cultures during 
in vitro wound healing   
One of the essential phases of wound healing is re-epithelialization, which is orchestrated 
by epidermal keratinocytes. This phase, upon wounding, involves the keratinocytes 
(those with close proximity to the wound edge) to be activated to a migratory cellular 
phenotype, followed by a proliferative burst that occurs just behind the migrating tongue 
(46,47) Studies have implicated mutual exclusiveness of these cellular processes 
(139,140), and thus it was pertinent to explore how and which of these processes are 
mostly attributable to the phenotypic differences in wound closure capacities of 
keratinocytes and melanocytes in a co-culture. The co-cultured cells at different ratios 
were subjected to mitomycin treatment (to inhibit proliferation) and wound closure over 
a 48 hour period was evaluated as a consequence of exclusive cellular migration.  
3.5.1. Evaluation of migration capacity (inhibition of proliferation by mitomycin 
treatment) of in vitro co-cultures  
To determine whether wound closure was due to migration of cells, we exposed the 
keratinocytes and melanocytes co-cultures to a mitogen inhibitor (mitomycin C) before 
inducing a scratch wound. To determine the effectiveness of the mitogen inhibitor, 
keratinocyte mono-cultures were treated with 10µg/µl of mitomycin C for 2.5 hours. 
Proliferation was halted without adversely affecting cellular morphology as early as three 






Figure 3.7: Evaluation of the effect of mitomycin C on proliferation of kerationocytes by 
means of growth curves. Cells were treated with 10µg/µl mitomycin C for 2.5 hours, and 
then cultured in DMEM for a maximum of 7 days. At days 1, 2, 3, 5 and 7, cells were lifted 
and counted. The graph represents the mean ± SEM values. n=3 
Following the addition of proliferation inhibitor to the co-culture models, we saw no 
significant differences in the migratory pattern of cells in co-cultures, despite the 20:1 
ratio showing a slightly superior, albeit non-significant, percentage wound closure at all-
time points post-scratch (Figure 3.8).   
 
 






























Figure 3.8: Evaluation of migratory pattern in various ratios of keratinocytes and 
melanocytes co-cultures (5:1, 10:1 and 20:1). Cells were treated with 10µg/µl mitomycin 
C for 2.5 hours. A scratch was made 24 hours post co-culturing. At 0, 12, 24, and 48 hours 
post scratching, three images per field of view were randomly taken using a camera and 
Image J software was then used to calculate % wound closure.  The % wound closure is 
represented as mean ± SEM. n=3 
This result compared to the previous result of the ratios without the mitogen inhibitor 
(Figure 3.6) points to the fact that the wound closure was not due to migration, but 
probably due to different rates of cellular proliferation at the wound site. Taken together, 
this led us to postulate that in a 20:1 ratio of keratinocytes to melanocytes, the cells may 
mainly proliferate and in so doing, close the wound.  
3.5.2. Evaluation of proliferative capacity of keratinocytes and melanocytes in 
vitro co-cultures  
With the hypothesis that the wound healing phenotype was due to the proliferative 
activity of co-cultured cells into the wound, we were interested in determining which of 
the two cell types (either or both keratinocytes and melanocytes) in various co-culture 
ratios were chiefly responsible for the proliferative wound healing phenotype. To realise 
this objective, co-cultures of keratinocytes to melanocytes (5:1, 10:1 and 20:1) were 
prepared, scratched and cultured for 48 hours post-wounding followed by the calculation 
of a proliferation index as detailed in materials and methods  (Section 2.2.5).  


























Figure 3.9: Determination of proliferation index (PI) in various ratios of keratinocytes 
and melanocytes co-cultures (5:1, 10:1 and 20:1). A scratch was made 24 hours post co-
culturing. At 0, 24, and 48 hours post scratching, cells were harvested, lifted and labelled 
with MART-1 and Ki-67. Ten thousand events were acquired through FACS followed by 
calculation of PI (as percentage Ki-67+ cells). Values represented as means, n = 3.  
There were no significant differences in the PI of both keratinocytes and melanocytes 
from the co-cultures; however there was a trend towards melanocytes being slightly 
more proliferative when compared to the keratinocytes (Figure 3.9). To further 
investigate the proliferative capacity of these cells, we compared the PI of mono-cultures 
to co-cultures (Figure 3.10). There were significant (p<0.05) differences at 24 hours post 
wounding in the PI of melanocytes when co-cultured, as compared to mono-cultures. On 
the contrary, keratinocytes in either mono-/co-cultures showed no significant 
differences in proliferation index.   
This finding is fascinating in light of the fact that the identical numbers of melanocytes 
are seeded and only the keratinocyte numbers change. Despite the melanocyte numbers 
not changing significantly between the different co-culture ratios (Figure 3.3), significant 
differences in proliferative index exist between the monoculture and co-cultured 
melanocytes (Figure 3.10A). This result further emphasises the influence of keratinocytes 
on melanocyte proliferation through paracrine mechanisms and corroborates the earlier 






























































Despite this being previously reported in different systems, such as in determination of 
melanin transfer from melanocytes to surrounding keratinocytes (130,134), this possible 
paracrine influence of melanocyte proliferation by keratinocytes has not been shown in 
primary human cultures with respect to wound healing.   
 
Figure 3.10: Comparison of proliferation index (PI) between keratinocyte and 
melanocytes mono- and co-cultures. A: Comparison of proliferation index (PI) of 
keratinocytes mono-cultures with keratinocytes sorted from co-cultures (5:1, 10:1 and 
20:1). B: Comparison of proliferation index (PI) of melanocytes mono-cultures with 
melanocytes sorted from co-cultures (5:1, 10:1 and 20:1). A scratch was made 24 hours 
post co-culturing. At 0, 24, and 48 hours post scratching, cells were harvested, lifted and 
labelled with MART-1 and Ki-67. Ten thousand events were acquired through FACS 
followed by calculation of PI (as percentage Ki-67+ cells). Values represented ± SEM 
values. n=3 
Taken together, the data so far implicates both keratinocyte and melanocyte 
proliferation, not migration as the major driving forces in wound healing post scratch.   
3.6. Effect of human fibroblast-derived factors on wound closure 
As wound closure involves both the epidermal and dermal cellular components of the 
skin, it was important in our in vitro model, to assess the wound healing influence of the 
dermal cell component i.e. fibroblasts. To investigate this, we harvested fibroblast-
conditioned medium, as opposed to culturing fibroblasts alongside the keratinocytes and 
melanocytes (which would result in the complexity of determining the optimal culture 
conditions). The fibroblast-conditioned medium was then added to the co-cultures at a 
dilution of 1:1 (co-culture medium to fibroblast conditioned medium) after which wound 
















































































Figure 3.11: Scratch assay images showing the wound closure of the keratinocyte to 
melanocyte ratios, following addition of fibroblast-conditioned medium. Magnification: 
100 X.  
Our data showed no significant differences in wound healing profiles for any of the ratios 
in co-culture. However, the 5:1 ratio showed a trend towards a slightly higher percentage 
(10% higher than all other ratios at each time point) wound closure (Figure 3.12). This is 
in contrast with the previous result (Figure 3.6), where the 20:1 ratio (without fibroblast 
conditioned medium) yielded a better wound healing outcome. As the 10: 1 ratio was not 
affected by the inhibition of proliferation, this ratio was omitted in subsequent 










Figure 3.12: Effect of human fibroblast-derived factors on wound closure. Keratinocytes 
and melanocytes co-cultures (5:1, 10:1 and 20:1) were scratched 24 hours post co-
culturing. At 0, 24, and 48 hours post scratching, three images per field of view were 
randomly taken using a camera and Image J software was then used to calculate % wound 
closure.  The %wound closure is represented as mean ± SEM. n=3  
To further investigate such subtle variations in wound closure capacities of our co-culture 
models (5:1 and 20:1 only), we graphed the percentage wound closure with or without 
addition of conditioned medium (Figure 3.13).  
The 5:1 ratio displayed significant differences (p < 0.001) in wound closure upon addition 
of fibroblast-conditioned medium at both the 12 and 24 hour time points (Figure 3.13A). 
In contrast, no significant differences were shown over the entire 48 hour time period for 
both the 10:1 (data not shown) and 20:1 ratios (Figure 3.13B), Despite the wound closing 
at the same time point (36 hours) in the 5:1 ratio, the result implies that fibroblast-
conditioned medium i.e. fibroblast-derived factors, elicit a faster rate of closure over the 
first 24 hours. This result supports the observations of Imokawa et al., (1998) (141) who 
showed that fibroblast-conditioned medium was capable of activating mitogen-activated 
protein (MAP) kinase of human melanocytes, causing them to proliferate in the presence 
of conditioned medium.  More recently, Cario-Andre et al., (2006) (142) also showed that 
fibroblast secretion significantly influences melanocyte proliferation and melanin 
distribution/degradation. Although the exact nature of the fibroblast-derived influence 
was difficult to isolate in our system, we can hypothesize that because there are more 

























melanocytes to keratinocytes in the 5:1 ratio, that the melanocytes may be the key players 
in the acceleration of wound closure in the presence of fibroblast-derived paracrine 
factors.  
 
Figure 3.13: Comparison of the effect of human fibroblast-derived factors on wound 
closure between 5:1 and 20:1 ratios. Keratinocytes and melanocytes co-cultures (5:1 and 
20:1) were scratched 24 hours post co-culturing as before. The %wound closure is 
represented as mean ± SEM. n=3  
Overall these data shows that fibroblast-derived factors have a positive effect on the 
wound healing capacity of cells in 5:1 ratio, whereas such factors may not be as beneficial 
with a higher ratio of keratinocytes to melanocytes (20:1). The possibility further exists 
that inhibitory factors or factors that cause rapid degradation of the fibroblast-derived 
mitogens, may be released into the milieu from the increased number of keratinocytes in 
the 10:1 and 20:1 ratios. This will have to be further investigated in the future. For these 
reasons, we wanted to determine how such variations were manifested and therefore 
treated our co-cultures with mitomycin C, followed by addition of conditioned medium 


















































3.6.1. Evaluation of migratory phenotype of co-cultures following addition of 
fibroblast conditioned medium 
 
Figure 3.14: Scratch assay images showing the wound closure of the ratios, following 
addition of mitogen inhibitor (mitomycin C) and fibroblast conditioned medium. 
Magnification: 100 X.  
Following the treatment of co-cultures with mitomycin C, no significant differences in 
percentage wound closure was observed in any of the ratios (Figure 3.15). Despite this, 
the 5:1 ratio fascinatingly displayed an increase in the rate of migration during the early 
wound healing phase (12-24h), followed by a non-significant drop in the migration rate 









migration rates over the same time period. Furthermore, 20:1 ratio displayed significant 
(p<0.05) reduction in the rate of migration, whereas the 10:1 ratio showed a uniform 
steady-state reduction in its migratory rate over time. Specifically, there was an inverse 
correlation in migratory potential of these two keratinocyte to melanocyte ratios -  in the 
5:1 ratio, the highest migratory rate was evident 24-36 hours post scratch (36 078µm/h), 
while the 20:1 ratio, displayed the fastest rate of migration (52 089µm/h) in the earlier 
(12-24 hours) phase of wound healing (Figure 3.16). 
 
Figure 3.15: Effect of human fibroblast-derived factors on cell migration. Keratinocytes 
and melanocytes co-cultures (5:1, 10:1 and 20:1) were treated with 10µg/µl mitomycin 
C for 2.5 hours and scratched at 24 hours post co-culturing. At 0, 24, 36 and 48 hours post 
scratching, three images per field of view were randomly taken using a camera and Image 
J software was then used to calculate percentage wound closure.  The percentage wound 
closure is represented as mean ± SEM. n=3  
 

























Figure 3.16: Determination of rate of migration in various co-culture ratios (5:1, 10:1 and 
20:1). The rate was calculated as µm/h and data represented as mean ± SEM. n=3 
Such variations in co-culture ratio-dependant wound healing capacities are important 
considerations in designing pigmented 3D skin constructs. A study by (131) showed that 
melanocyte titration is pivotal in the control of pigmentation in skin constructs. They 
showed, expectedly, that higher number of melanocytes yielded a better pigmentary skin 
phenotype. Another study conducted by (143) convincingly showed that addition of 
melanocytes onto 3D skin constructs yielded the similar colour to the donor skin. 
Therefore, this may also hold true for proliferation and migration, which are both 
important facets of epithelial wound healing. With this in mind, we sought to infer if any 
of these differences were existent, and if so how would they impact on the wound healing 
capacities of either melanocytes or keratinocytes in co-culture.   
3.7. Evaluation of migratory and/or proliferation phenotype in co-cultures, 
with or without addition of fibroblast conditioned medium (Fb-CM)  
Such differences in migratory rate (i.e. the 5:1 ratio displaying a late peak migratory rate 
and the 20:1 ratio showing an earlier peak migration rate) may be correlated to the 
proliferation capacities of cells in co-culture. Since it is well documented that 
proliferation and migration are mutually exclusive events in cellular dynamics (139,140), 
we observed an early significant increase in proliferation capacity of cells in a 5:1 ratio 
(Figure 3.13) 12-24 hours post-scratch upon addition of Fb-CM, which was accompanied 
 5:1















































































by a late non-significant increase in migratory rate (Figure 3.16) that occurred 36 hours 
post-scratch.   
This early proliferation capacity of cells in the 5:1 ratio was deduced from the observation 
that there was a significant increase in percentage wound closure upon the addition of 
Fb-CM (red line to green line in Figure 3.17). In contrast, this increase was abrogated 
upon the addition of a proliferation inhibitor (Green to blue lines) (Figure 3.17). 
 
Figure 3.17: Evaluation of migratory and/or proliferation phenotype in 5:1 co-culture 
ratio, with/without addition of fibroblast conditioned medium. Cells were co-cultured; 
thereafter Fb-CM and/or mitomycin C were added post scratch. Scratches were 
monitored for 48 hours. Data is represented as mean ± SEM. n=3  
3.8. Evaluation of migratory and/or proliferation phenotype in mono-cultures, 
with/without addition of fibroblast conditioned medium  
Having observed such variations in wound closure capacities of cells in various co-culture 
models, we set out to determine the role of each cell type in effecting these changes. To 
do this, keratinocyte and melanocyte mono-cultures were scratched as before, followed 
by the addition of Fb-CM and/or mitogen inhibitor.  
Interestingly, addition of Fb-CM to keratinocyte mono-cultures led to a significant 
(p˂0.05) delay in wound closure at 36 hours post-scratch (Figure 3.18). The melanocytes 
in contrast, only exhibited a significant difference (p˂0.01) in wound closure 48 hours 
after being wounded (Figure 3.18). Addition of the proliferation inhibitor, mitomycin C, 
resulted in a rescuing of the wound closure capacity of keratinocytes, which supports the 
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hypothesis that keratinocytes’ migratory phenotype is favoured upon addition of Fb-CM. 
On the other hand, melanocytes showed no differences in percentage wound closure 
following addition of the fibroblast conditioned medium and mitomycin C (Figure 3.18).  
In support of a number of reports (53,54,141), this difference between the two cell types’ 
responses may be due to fibroblast derived factors such as bFGF and ET-1. It is suspected 
that in this system, these factors are responsible for the increased proliferation in 
melanocyte mono-cultures, whereas some of these factors seem to slow down 
keratinocyte proliferation, in favour of their migration (139,140).  
 
Figure 3.18: Evaluation of migratory and/or proliferation phenotype in mono-cultures, 
with/without addition of fibroblast conditioned medium. Cells were cultured; thereafter 
Fb-CM and/or mitomycin C were added post scratch. Scratches were monitored for 48 
hours. Data is represented as mean ± SEM. n=3  
Taken together, such Fb-CM studies have highlighted the importance of partially 
inhibiting proliferation in keratinocytes, while allowing for subsequent melanocyte 
proliferation. Such growth dynamic variations seem to be ideal in enhancing wound 
closure capacities in our co-culture models (where we see increased percentage wound 
closure in a 5:1 ratio, upon addition of Fb-CM) and have a direct application to the clinical 
response of wound healing.    
3.9. Pigmentary phenotypes of co-cultures 
Tyrosinase and TRP-1 are two of the best-characterised melanocyte differentiation 
proteins associated with melanin synthesis (144). Our question was therefore to evaluate 
whether the presence of keratinocytes in co-cultures with the melanocytes, affect their 
level of pigmentation.  The challenge was to analyse this aspect after co-cultures. This was 
Kc mono-cultures
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overcome by labelling the cells with a melanocyte-specific antibody (MART-1) and then 
quantifying the number of TRP-1-positive cells as a marker of differentiated, pigmented 
melanocytes using fluorescent activated cell sorting (FACS).  While we observed a 
significant (p<0.0001) reduction in pigmented  “melanogenic-competent”/TRP-1-
positive melanocytes in the co-cultures compared to mono-cultures, no significant 
differences in TRP-1 positivity existed between the individual ratios (Figure 3.19). A 
number of reasons could be postulated for this seemingly lack of “melanogenesis-
competent” cells in co-culture. Firstly, (131) showed that a decrease in pigmentation of 
their cultured skin constructs was due to the dilution of slow growing melanocytes by the 
fast growing keratinocytes. Corroborating this was a study by (132) who observed not 
only a decrease in melanocyte numbers, but an associated decrease in pigmentary 
function (as evidenced by a lack of TRP-1 expression). They postulated this to be a 
possible factor for subsequent melanocyte loss.  
 
Figure 3.19: Evaluation of pigmentary phenotype of melanocytes in mono-/co-cultures 
with keratinocytes (5:1, 10:1 and 20:1Cells were co-cultured for 3 days, thereafter lifted, 
permeabilised and labelled with MART-1 and TRP-1. A: FACS was used to acquire 10 000 
events. B: Melanogenic melanocytes represented as MART-1+/TRP-1+ cells. n=3  
Despite the lack of pigmentation in our co-cultures, we hypothesise that when 
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subsequently re-pigment due to the presence of fibroblasts in the prospective PSE 
models. Although the testing of this hypothesis falls beyond the scope of this study, a 
study by (145) using a 3D construct showed that dermal fibroblasts do indeed impact the 



















CHAPTER 4: CONCLUSIONS AND FUTURE PERSPERCTIVES 
The overall aim of this study was to, through the use of primary isolated skin melanocytes 
and keratinocytes develop an in vitro co-culture system to obtain optimal pigment 
production in vitro and to evaluate its applicability to an improved wound healing 
outcome. Specifically, the study was set out to analyse the effect the co-cultured 
epidermal cells (at various ratios) may have on characteristics associated with wound 
healing such as cell proliferation and migration. Furthermore, we were interested in 
determining the pigmentary phenotype of such co-cultures. Therefore keratinocytes and 
melanocytes were co-cultured at 5:1, 10:1 and 20:1 ratios respectively.  
Firstly the proliferation capacities of both keratinocytes and melanocytes in co-culture 
were evaluated. Melanocyte’s proliferation capacity increased with their subsequent co-
culture with keratinocytes in all ratios, with the highest proliferation in the 5:1 ratio. On 
the contrary, keratinocytes proliferated better with less of melanocytes (20:1) in co-
culture. These implied that melanocytes are hugely dependant on keratinocyte derived 
factors for proliferation, whereas keratinocytes are negatively impacted by greater 
melanocyte numbers.  
Secondly, wound healing phenotypes of co-cultured keratinocytes and melanocytes were 
evaluated. The significantly better wound healing capacity was much more evident with 
the 20:1 ratio, where such was attributed to the increased proliferative capacity of cells 
into the denuded area. This significantly better wound healing outcome was abrogated 
by the subsequent presence of fibroblast derived factors, which in turn enhanced the 
proliferative capacity of melanocytes, while increasing the migratory pattern of 
keratinocytes in co-culture. This resulted in a non-significantly superior wound healing 
outcome in the 5:1 ratio of keratinocytes to melanocytes. It is in this ratio where we also 
observed a synchronised population doubling time (approximately 48 hours) of both 
epidermal cells in co-culture.   
Thirdly, the pigmentary phenotypes of the three ratios of co-cultures was evaluated, 
where we observed a significant reduction in number of TRP-1+ melanocytes when co-
cultured with keratinocytes compared to melanocytes mono-cultures. Alongside this 
observation, all co-culture ratios exhibited similar low numbers of “melanogenic-
competent” melanocytes. This further highlights the tight regulation of keratinocytes in 
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preventing melanocytes from being fully differentiated, thus not being capacitated to 
pigment.  
Therefore, we finally postulate that a 5:1 ratio would be a better ratio to incorporate into 
our prospective PSE (pigmented skin equivalents), as in this co-culture ratio, melanocytes 
and keratinocytes growth rates were similar, and also because such ratio yielded a better 
wound healing outcome in the presence of fibroblast derived factors. Furthermore, the 
presence of the highest number of melanocytes may result in a greater pigmentation 
outcome in the presence of fibroblast derived factors, though this will have to be tested.  
However, few limitations exist in this study. Firstly immortalised keratinocytes; HaCaTs, 
instead of primary keratinocytes were used throughout this study. One could imagine 
that such spontaneously transformed cells may be tumorigenic or may exhibit abnormal 
genotypic and phenotypic characteristics. However, a study by Boukamp et al., 1988 
(125) has shown that HaCaTs, similar to normal keratinocytes form an orderly structure, 
with normal differentiation patterns when transplanted onto nude mice. Pivotal 
differentiation markers such as K1, K10, involucrin and filaggrin are also expressed and 
regularly located. Furthermore, these transformed cell line possesses the normal DNA 
fingerprint pattern, which remains unaffected during pro-longed cultivation in vitro. The 
use of primary human keratinocytes seems an obvious choice. However, in our lab, we 
have experienced short life-span of these cells in vitro. The cells cannot be cultured 
beyond passage 4, therefore the use of immortalised cell line seemed the best option for 
this undertaking. We are however optimising the growth conditions of primary 
keratinocytes as these cells will have to be used in the development of PSE models.  
Another limitation is the use of infant foreskin melanocytes in place of normal skin 
melanocytes. Foreskin melanocytes due to their juvenile nature grow faster than adult 
skin melanocytes. Therefore the use of the latter cells would imply slow cell expansion 
during development of PSE models. However, it has been mentioned (paragraph below) 
that the addition of skin fibroblasts and correct keratinocyte cells numbers could 
potentially increase melanocytes’ proliferative capacity.   
In future, as previously mentioned, further studies to evaluate the pigmentation 
competence of melanocytes in co-culture with keratinocytes in the presence of fibroblast 
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derived factors is of great importance. This postulation is driven by the observation that 
melanocyte proliferation is enhanced by such growth factors, which may in turn increase 
the pigmentation. Furthermore to enhance their melanogenic capacity, we could subject 
melanocytes to low dose UV, or co-culture them with less differentiated keratinocytes as 
these have been shown to release a greater magnitude of paracrine factors essential for 
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APPENDICES   
Appendix A: Media used in the study 
Quantity sufficient (qs) is defined as enough liquid (e.g. ddH2O) that is used to make up 
a certain final volume, given in litres or millilitres. 
 
DMEM (pH 7.4, 1L) 
 
DMEM powder  27.06g 
NaHCO3 7.4g 
Autoclaved ddH20  qs 
Adjust to pH 7.4, sterilize through a 0.2µm filter and store in aliquots at 4oC 
 
Complete culture medium (DMEM/10%FCS/1xP/S, 200ml) 
 
FCS (100%) 20ml 
P/S (100x) 2ml 
DMEM (pH7.4)  qs 
Store in aliquots at 4oC 
 
FETI (1L) 
Component  Concentration  Volumes  
FCS 2% 10ml 
Ultroser G 1% 5ml 
hFGF-2 2ng/ml 100µl 
ET-1 2ng/ml 100µl 
TPA 16nM 200µl 
IBMX 0.05mM 5ml 
P/S 100U/ml; 100µg/ml 5ml 
Hams F10  qs 












Component  Concentration  Volumes  
DMEM/F12 1:1 qs 
Insulin 5µg/ml 2ml 
Hydrocortisone 0.4µg/ml 1.6ml 
Cholera toxin 0.1nM 800µl 
T/T3 2nM 800µl 
EGF* 10ng/ml 800µl 
P/S 100U/ml; 100µg/ml 8ml 
Gentamycin 0.2mg/ml 16ml 
Sodium bicarbonate 0.075% 8ml 
HEPES buffer** 20mM 16ml 
FCS 10% 80ml 
   
Filter sterilize through a 0.2µm filter, 
*add EGF after re-filtering 
**Make HEPES (1M) fresh 
Store in aliquots at -20oC  
 
KSFM complete medium (1L) 
 
EGF (2.5µg) 0.5ml 
BPE (25µg) 2.5ml 
P/S (1x) 5ml 
KSFM 500ml 










Appendix B: Buffers 
Hanks Buffered Saline Solution (HBSS, 1L) 
 
HBSS powder 9.5g 
NaHCO3 0.35g 
Autoclaved ddH20 qs 
 
HEPES buffer (1M, pH 7.3, 10ml) 
 
HEPES 2.383g 
ddH20  qs 
Make up fresh for Greens medium  
 
Phosphate Buffered Saline (1xPBS, 0.14M NaCl, 8.8M Na2HPO4, 2.7M KCl, 1.47M 






ddH20  qs 












Appendix C: Solutions 
Dispase (5mg/ml) 
 
Dispase 11 500mg 




EDTA (disodium salt) 0.25g 
PBS 500ml 
Sterilize through a 0.2µm filter and store in aliquots at -20oC 
 
Endothelin-1 (ET-1, 10µg/ml)  
 
ET-1  0.1mg 
PBS 1ml 
ET-1 (solution, 10µg/ml) 
ET-1 (10µg/ml) 100µl 
PBS 400µl 
Aliquot at store at -20oC 
 
Fetal Calf Serum (FCS, 500ml) 
 
FCS 500ml 
Heat inactivate by 20 minutes incubation in a 56oC water bath  




Hoechst (1000 μg/ml) 20 μl 
autoclaved ddH2O 900 μl 







IBMX (isobutyl-1-methyl xanthine; 20ml, 5mM) 
 
IBMX (to make 10mM) 0.022g 
ddH2O 10ml 
Autoclave, then allow to cool 
IBMX (10mM) 10ml 
Hams F10  10ml  




L-Glutamine  2.92g 
ddH2O 100ml 
Sterilize through a 0.2µm filter and store in aliquots at -20oC 
 




PBS 10 ml 
Make fresh  
Mitomycin C (0.01µg/µl, 2ml) 
 
Mitomycin C  2mg 
SABAX H20 2ml 
Filter through a 0.2µm filter, wrap in foil and store in aliquots at -20oC 




Tris buffer (0.2 M) pH 8.5 12ml 
ddH2O 6ml 
Stir for a few hours at 50oC, centrifuge at 12000 rpm for 20 min. Store 







Mowviol with anti-fade  
 
Mowiol 1 ml 
n-Propyl gallate (Sigma-Aldrich, USA) tip of a small spatula 
Vortex and heat at 50oC for 1 h, mixing occasionally. Centrifuge at 13000 
rpm for 15-20 min. Transfer supernatant to clean tube and store at -20oC. 
Penicillin (1000U/ml)/ Streptomycin (100µg/ml) (100x P/S, 1L) 
 
Penicillin (1662 U/mg) 6g 
Streptomycin (750 U/mg) 10g 
ddH20  qs 
Sterilize through a 0.2µm filter and store in aliquots at -20oC 
PFA (4%, 100ml) 
 
Paraformaldehyde  4g 
PBS qs 
Heat at 50oC to dissolve and store in aliquots at -20oC 
Sodium phosphate buffer (1 M, 200 ml) 
NaH2PO4·2H2O 15.6 g 
Na2HPO4 ·12H2O 35.8 g 
ddH2O  qs 
Adjust to pH 7-7.4 and store at room temperature 
Sodium Phosphate Buffer (0.1 M, pH 7.2, 100 ml) 
Sodium phosphate buffer (1 M)  10 ml 
ddH2O qs 












TPA (12-O-tetradecanoylphorbol-13-acetate, 2mM stock) 
 
TPA (powder) 10mg 
Absolute ethanol  1ml 
Transfer to a 1ml tube  
TPA (solution) 1ml 
Absolute ethanol 7.11ml 
Aliquot and cover with foil, store at -20oC 
 
Triton X-100 (1%, 100ml) 
 
Triton X-100 1ml 
ddH20  99ml 
Allow to dissolve at room temperature overnight.  
 
Trypsin/EDTA (0.25% T/0.05% E, 100ml)  
 
Trypsin  0.25g 
EDTA 0.005g 
PBS qs 














Appendix D: Reagents 
Name  Product number  Supplier  
Acetic acid (glacial) 100% SAAR1021020LC Merck 
Albumin, from bovine serum  A7906 Sigma-Aldrich 
BCA Protein Assay Kit (Roche)  23225 Thermo Scientific Pierce 
Cholera toxin C8052 Sigma-Aldrich 
DMEM N.P02 Highveld Biological  
DMEM/F12 31600-83 GIBCO, Life Technologies 
DOPA  D9628 Sigma-Aldrich 
EDTA  E9884 Sigma-Aldrich 
EGF E5036 Sigma-Aldrich 
ET-1 E7764 Sigma-Aldrich 
Ethanol absolute  1.00983.2500 Merck  
Fetal Calf Serum  
 
No.306 GIBCO, Life Technologies/ 
Highveld Biological  
hFGF-2 130-104-924 Miltenyi Biotec 
FITC Anti-Human IL-2 340448 BD Biosciences 
Fungizone  No. 228 Highveld Biological 
Gentamycin G1272 Sigma-Aldrich 
L-Glutamine   21051-016 GIBCO, Life Technologies 
Glycerol   2676500LC Merck 
Hams F10 No. P08 Highveld Biological 
HCl (37%)  SAAR3063054LCA Merck 
HBSS No. P206 Highveld Biological  
HEPES  H3375 Sigma-Aldrich 
Hoechst  33342 H1399 Merck 
Hydrocortisone H0888 Sigma-Aldrich 
IBMX I5879 Sigma-Aldrich 
Insulin Reg: W/22.1/288 Novo Nordisk (Pty) Ltd 
Isopropanol  SAAR5075040LC Merck 
KCl (potassium chloride)  SAAR5042000EM Merck 
KH2PO4 (potassium dihydrogen 
orthophosphate)  
10203 BDH 
KSFM 17005-034 GIBCO, Life Technologies 
Methanol  SAAR4164060LP Merck 
Microscope cover glasses 
22x22mm 
101050 Marienfeld 
Microscope slides   1001412 Marienfeld  
Mitomycin C M4287 Sigma Aldrich  
Mowiol  P3130 Sigma Aldrich  
NaCl (sodium chloride)  SAAR5822320EM Merck 
 
88 
Na2HPO4 (di-sodium hydrogen 
phosphate) 
1.06586.0500 Merck 
PFA (paraformaldehyde) S55065-016 Merck  
Penicillin G sodium salt  P3032 Sigma-Aldrich 
Transferrin T0665 Sigma-Aldrich 
Streptomycin  S9137 Sigma-Aldrich 
Supplements for KSFM 37000-015 Sigma Aldrich  
TPA P1585 Sigma-Aldrich 
Triton X-100 T9284 Sigma-Aldrich 
Trypsin, from porcine pancreas  T4799 Sigma-Aldrich 
T/T3 T6397 Sigma-Aldrich 
Tween-20  P9416 Sigma-Aldrich  



















Appendix E: Tables 
Table E.1: Number of cells used for a scratch assay  
Ratio Keratinocytes Melanocytes 
5:1 4.5 x 105 9 x 104 
10:1 4.5 x 105 4.5 x 104 
20:1 4.5 x 105 2.25 x 104 
Keratinocyte control 4.5 x 105 - 
Melanocyte control - 5 x 105 
 
Table E.2: Number of cells used for co-culture proliferation (growth curves) assays  
Ratio Keratinocytes Melanocytes 
5:1 4.5 x 105 9 x 104 
10:1 4.5 x 105 4.5 x 104 
20:1 4.5 x 105 2.25 x 104 
Keratinocytes    
Melanocytes    
 
Table E.3: Number of cells used for co-culture proliferation Index (PI)  
Ratio Keratinocytes Melanocytes 
5:1 9 x 105 1.8 x 105 
10:1 9 x 105 0.9 x 105 
20:1 9 x 105 0.45 x 105 
Keratinocytes  9 x 105 - 
Melanocytes  - 7.5 x 105 
 
Table E.4: Number of cells used for TRP-1 staining (for FACS) 
Ratio Keratinocytes Melanocytes 
5:1 1x 105 2x 104 
10:1 2x 105 2x 104 
20:1 4x 105 2x 104 
Keratinocyte control 5 x 105 - 







Table E.5: Antibodies used in this study.  
Antibody  Concentration  Supplier  
MART-1 (FITC) 1µg Santa Cruz Biotechnology  
Ki-67 (PE) 2µg Santa Cruz Biotechnology  





























Appendix F: supplementary protocols  
Mycoplasma test – Hoechst 
 
To test for the presence of mycoplasma in the cultures, cells were grown in their 
respective medium on coverslips for 7 days without antibiotics. The growth medium was 
then removed and cover slips (with cells) were washed with 1x PBS. Cells were fixed with 
1 ml glacial acetic acid:methanol (1:3) for 6 minutes at room temperature, thereafter, 
fixative was removed and cover slips were allowed to air-dry. Cells were subsequently 
stained cells with 5µg/ml Hoechst for 6minutes. Hoechst was removed and cells were 
washed a few times with 1x PBS. Finally the coverslips were mounted onto microscope 
glass slides, after which cells were viewed on a fluorescent microscope. 
Optimisation of co-culture growth conditions (GREENS/FETI) 
One of the fundamentals of Co-culturing is the determination of optimal growth 
conditions for both cell types. Such includes mainly the growth medium conducive for 
both cells in a co-culture. Typically, a mono-culture of HaCaT cell lines is grown in DMEM, 
while the optimal growth medium for melanocytes is FETI. Therefore in this study, the 
optimal growth medium for HaCaT cell lines and melanocytes in a co-culture was 
determined as follows: 
Primary skin melanocytes (2x104 cells) were seeded in 35mm dishes in duplicate and 
cultured for a period of 7 days. The cells were grown in either FETI or GREENS, during 
which at days 1, 2, 3, 5 and 7, cells were lifted off the dishes by means of trypsin/EDTA 
and counted as mentioned in Section 2.1.3.  Similarly, HaCaT cells (2x104 cells) were 
seeded, cultured in either GREENS or FETI and counted at aforementioned days. For all 
experiments, 3 biological repeats were done.    
 
Optimisation of FACS analyses for co-cultures (MART-1/Ki-67 and MART-1/TRP-1) 
In order to separate the two cell types, FACS was used to sort such cells following labelling 
with specific antibodies. In the same manner, we used FACS analyses to decipher the 
various cell populations with different phenotypic changes. For instance, we used MART-
1/Ki-67 and MART-1/TRP-1 antibody combinations to infer the proliferation and 
melanogenic capacities respectively, of melanocytes from a co-culture.  
 
92 
In order to optimise the separation technique, briefly cells were cultured as indicated in 
Table E2 for 24 hours, followed by trypsinisation as before. The cells were re-suspended 
and fixed in 2ml of cold 4% paraformaldehyde for 15 minutes at ambient temperature 
and washed twice in PBS. Cells were then permeabilized for 15 minutes using a 
perm/wash buffer following manufacturer’s instructions.  Cells were re-suspended in 
FACS buffer and transferred to FACS tubes. Finally a melanocyte specific antibody; 1µg of 
MART-1 conjugated to FITC was added to the cell suspension and tubes were covered in 
foil to prevent light exposure. The cells were incubated for 1 hour at ambient temperature 
on a shaker and washed with perm/wash buffer. The cells were then re-suspended in 
FACS buffer and immediately acquired (10 000 events or total cell population) on a flow 
cytometer.  Table indicates the antibody combinations used for various assays.  
Table F.1: The antibody concentrations used for specific assays.  
Antibody  Concentration  Assay   
MART-1 (FITC) only  1µg Growth curves  
MART-1 (FITC)/Ki-67 (PE) 1µg/2µg Proliferation index 

















Appendix G: supplementary data  
Optimisation of co-culture growth conditions 
 
Figure F.1: The growth curves of immortalised human keratinocytes cultured in either 
DMEM or GREENS, and that of primary skin melanocytes cultured in either FETI of 
GREENS for a maximum of 7 days. At days 1, 2, 3, 5 and 7, cells were trypsinised and 
counted. Cell numbers are presented as mean ± SEM values. n=3.  
Mono-cultures in their native media exhibit a much better growth as compared to when 
cells are cultured in GREENS (Figure F.1). However, when both keratinocytes and 
melanocytes are grown in a co-culture, there seems to be a stable maintenance of 
melanocyte numbers in a co-culture, with keratinocytes depicting much better growth 
rates in a co-culture (Figure F1; Section 2.2). Overall, these data let us to choose an 
optimal growth medium as GREENS due to that it relatively supports growth of these cells 
in a co-culture setting. Therefore all subsequent co-culture experiments were done in 
GREENS. 
 
Optimisation of FACS analyses for co-cultures 
The FACS separation technique worked excellently in deciphering keratinocyte 
population from melanocytes, with an almost 100% accuracy. This is shown by 
melanocytes being sorted as 93% of MART-1+ cells in a mono-culture, followed by an 
approximately 5:1 separation of keratinocytes from melanocytes (77% Kc and 17% Mc), 
as shown in Figure F.2.  We therefore used this separation technique for all subsequent 
co-culture experiments.  
 
 




























































Figure F.2: Optimisation of the separation technique of keratinocytes and melanocyte co-
cultures. Cells were culture overnight as either mono-/co-cultures, and then cells were 
trypsinised, fixed, permeabilised and acquired by FACS. Kc represented as MART1- cells, 













Kc (MART-1) Kc:Mc (5:1) MART-1 Mc (MART-1) 
Kc (unstained ) Mc (unstained )
